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Abstract 
Adenoviruses are common pathogens, causing a number of infectious diseases. 
They have been found in virtually all human organs, producing symptoms that 
range from the common cold to pneumonia (Hakim and Tleyjeh, 2008). 
Additionally, they also cause a variety of clinical symptoms, for example 
epidemic keratoconjunctivitis (EKC), pharyngoconjunctival fever (PCF), infantile 
gastroenteritis, cystitis and urinary tract infections. Individuals with poorly 
functioning immune systems are especially prone to severe and life-threatening 
infections. Among these are persons infected with HIV, or organ transplant 
patients (Hoffman, 2006). In 1977 Philip Sharp and Richard Roberts discovered the 
ability of Adenoviruses to split genes (e.g. splicing), and they were in 1993 
awarded the Nobel Prize in Physiology and Medicine for their discovery. Today, 
Adenoviruses are mostly studied for the ability to be used as delivery vehicles in 
gene therapy. About 25% of all clinical gene therapy trials are performed with 
Adenovirus-based vectors, making Adenoviruses the largest group (Edelstein et 
al., 2007). In this thesis we exclusively studied Adenoviruses binding to the cellular 
receptor CD46, characterizing the interaction at an atomic level. We 
experimentally connected structure and function, defining the Adenovirus 
interaction with CD46. The structures presented in this thesis will have implications 
for future drug design, focusing on reducing complications due to Adenoviruses 
during organ transplantation. Furthermore, our findings will significantly improve 
general knowledge of Adenovirus:receptor interactions, which will facilitate the 
development of more efficient gene delivery vehicles. 
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1 Introduction 
1.1 History 
It was only about 100 years ago, at the end of the nineteenth century that the 
first viral pathogen was discovered. A pathogen was then defined as an 
organism that could be observed with a microscope, cultivated in nutrient 
medium, and be retained by filters.  At this point, apart from a few toxins, very 
few infectious agents did not fulfill these criteria. In 1898, Dmitri Iwanowski was 
able to show that the causative agent of a mosaic disease of tobacco plants 
did not fulfill any of the criteria. Iwanowski was unimpressed by his findings, but in 
1898 Martinus Willem Beijerinck repeated Iwanowski’s experiments and 
discovered a new infectious agent that he called contagium vivum fluidum, 
what we today know as a virus. In the same year, Loeffler and Frosch came to 
the same conclusion regarding the cause of foot and mouth disease. This 
disease could be transferred from animal to animal with large dilutions in each 
passage, suggesting a replicating pathogen and not a toxin (Dimmock, 2007). 
Today, some properties are known to all viruses and thus define a virus.  
Viruses have: 
 
• a nucleic acid genome of either DNA or RNA 
• genomes associated with protein that at its simplest forms the virus 
particle, but in some viruses this nucleoprotein is surrounded by additional 
protein or a lipid bilayer 
• the ability to reproduce only in living cells 
• the ability to recognize the correct host cell and gain entry to its 
cytoplasm by use of the outer most proteins 
 
Adenoviruses (Ads) were isolated and cultured for the first time in 1953 by 
Wallace P. Rowe and colleagues (Rowe et al., 1953). The virus was isolated from 
adenoids and tonsils in children, where it caused a degeneration of epithelial-like 
cells.  The symptoms caused by this viral agent were called adenoid 
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degenerating (A.D), adenoid-pharyngeal conjunctival (APC) and acute 
respiratory disease (ARD). The name Adenovirus was used for the first time in 
1956, although possible adenovirus symptoms are documented 100 years earlier 
(Dingle and Langmuir, 1968). In 1962, it was shown that Adenoviruses also have a 
tumor activity in mice and hamsters (Fields, 1996), providing the first evidence of 
a human pathogen causing malignant tumors in an animal model. To date, no 
convincing results have been obtained of a malignant tumor activity in humans. 
In total, five polygenetic genera of Adenoviruses have been defined, which 
infect a broad range of host organisms. 
1.2 Taxonomy 
Adenoviruses have so far only been isolated from vertebrates. The Adenoviridae 
(Benkö, 2006) family of viruses is divided into four defined genera and one 
suggested genus according to the International Committee on Taxonomy of 
Viruses (ICTV) (Büchen-Osmond, 2003). The first genus is Atadenoviridae (Benkö, 
2006) with a name reflecting the high AT base pair content in the viral genome. 
The genus infects ruminants (Bartha, 1969; Boros et al., 1985; Lehmkuhl and Cutlip, 
1999), birds (Harrach et al., 1997), snakes (Benkö et al., 2002; Farkas et al., 2002) 
and marsupial hosts (Thomson et al., 2002). The second genus, Aviadenoviridae 
(Benkö, 2006), infects exclusively birds (Schrenzel et al., 2005) and a third genus 
Siadenoviridae (Benkö, 2006) infecting birds and frogs (Davison et al., 2000; 
Pitcovski et al., 1998). The fourth genus is Mastadenoviridae (Benkö, 2006) and 
infects exclusively mammals. One adenoviruses genus, Ichtadenoviridae, infects 
fish but is not yet accepted by the ICTV (Benkö et al., 2002; Kovacs et al., 2003). 
Each genus is further divided into species with names from the host and letters 
from the alphabet. Species designation of Adenoviruses depends on a number 
of characteristics like oncogenicity, cross reacting antibodies, and agglutination 
properties, among others. 
In this study we exclusively worked with human Adenoviruses. When we 
refer to Adenoviruses (or Ads) we always imply human Adenoviruses. The human 
adenoviruses consist of a total of 51 serotypes classified into six subgenera, 
designated A-F, that cause a wide range of symptoms (Benkö, 2006) (Table 1). 
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Table 1. Properties of human adenoviruses species A-F 
 
Species Serotype Infects 
A 12, 18, 31 Intestine 
B:1 3, 7, 16, 21, 50 Respiratory tract, eye 
B:2 11, 14, 34, 35 Respiratory and/or 
urinary tract, eye 
C 1, 2, 5, 6 Respiratory tract 
D 8-10, 13, 15, 17, 19, 20, 22-30, 32, 
33, 36, 37-39, 42-49, 51 
Eye, intestine 
E 4 Respiratory tract, eye 
F 40, 41 Intestine 
 
An additional term used for classification is the “prototype”. The first strain 
isolated is normally the prototype strain, indicated by a “p” for prototype (for 
example Ad11p). Strains differing from the prototype are designated type “a, b, 
c” (for example Ad11a). The isolates are also given a specific strain name (for 
example Ad11p: Slobitski). 
1.3 The Adenovirus structure  
Adenoviruses are non-enveloped dsDNA viruses, between 70-90 nm in size, with 
icosahedral symmetry (Brenner and Horne, 1959). The spherical capsid has a 
diameter of about 900 Å (Stewart et al., 1991), with an estimated molecular 
weight of 150x106 Da including DNA (Burnett, 1985; Burnett et al., 1985). 
Adenoviruses, regardless of which host they infect, all share this morphology. The 
252 “capsid building blocks” forming the external surface consist of 240 copies of 
the hexon, arranged such that they have six fold symmetry, and 12 pentons at 
the vertices of the icosahedron with five fold symmetry. From each center of the 
penton an elongated fiber protrudes that terminates in a globular knob. The 
knobs primarily mediate cellular attachment, whereas the penton bases trigger 
the viral uptake (Figure 1). 
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Figure 1. The adenovirus particle. (A) Drawing of the adenovirus particle, with different 
structural proteins marked in: olive (penton), green (penton Base), blue (hexon) and red 
(fiber). Picture modified from Madd Graphix Inc (www.maddgraphix.com). (B) Quasi-
atomic model of the Ad5 particle at a resolution of 10 Å. The yellow pentagons indicate 
the five fold rotation axes, the triangles the three fold rotation axes, and the ellipses the 
two fold rotation axes. The outer edge of one hexon trimer is outlined in red. Each facet is 
built up by four trimers of the hexon, here outlined in red and white. Figure B obtained 
from Fabry (Fabry et al., 2005). 
 
 
There are in total 11 structural proteins, but only the major capsid proteins will be 
described here in greater detail (hexon, penton and fiber). The virus also 
encodes about 30 non-structural proteins. These will not be discussed as they are 
of no importance for receptor interactions, which is the focus in this thesis, but 
possess regulatory and catalytic functions (San Martín, 2003). 
1.4 Adenovirus structural proteins 
1.4.1 Hexon (polypeptide II) 
The hexon protein is the most abundant protein of the adenovirus particle. It is 
responsible for 63% of its total protein mass (Burnett et al., 1985), and contains 
about 950 amino acids. The first X-ray structure of the Ad2 hexon was published in 
1985, but was followed by several additional hexon structures (Athappilly et al., 
1994; Burnett et al., 1985; Roberts et al., 1986; Rux and Burnett, 2000; Rux et al., 
2003) (Figure 2A-B). The hexon folds into two 8 stranded jellyroll like β-sheets (Voet 
Donald, 2004). The top of the molecule contains three loops and makes up most 
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of the outer surface of the capsid. With the crystal structure, a quasi atomic 
model was built by docking the Ad2 hexon into a 35 Å resolution cryo-EM 
reconstruction from 1991 (Athappilly et al., 1994; Stewart et al., 1991; Stewart et 
al., 1993).  The reconstruction has been drastically improved since then, and the 
best available structure is now at a resolution of 10 Å, built with the Ad5 hexon 
(Fabry et al., 2005) (Figure 1B).  
 
Figure 2.  Cartoon representation of the major capsid component, the hexon of Ad5 
(PDB accession number 1P30). (A)Side view of one protomer in the trimer, showing the 
two jelly roll β-sheets and the surface-exposed loops. (B) The hexon polypeptide forms 
trimers shown in blue, green and red. The view is along the three fold rotation axis, 
looking down onto the capsid. Figures made in PyMOL (DeLano, 2002).  
 
 
The hexon trimers have a remarkable stability due to their unusual topology (Rux 
et al., 2003). The N-terminus of each hexon chain spans the base of the 
molecule, making contacts with each of the three subunits. The hexon retains its 
physical and immunological characteristics even after exposure to 8 M urea 
(Shortridge and Biddle, 1970). The observed high conservation of amino acids at 
the base of the hexon molecule is probably due to packing restraints within the 
capsid (Rux et al., 2003). The hexon can be exchanged among different 
serotypes (Gall et al., 1998; Youil et al., 2002), indicating that the substitutions in 
the sequence are mainly in surface exposed loops. The hypervariable regions are 
the major targets for antigenic determinants, as expected for a specific immune 
response (Crawford-Miksza and Schnurr, 1996).  
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1.4.2 Penton base (polypeptide III) 
The penton base “glues” each of the hexon trimers together through its position 
at the 12 five fold rotation axes in the virus capsid. The second function for the 
penton base is during internalization of the virus particle, when its Arg-Gly-Asp 
(RGD) motif interacts with integrins of the αv type (Nemerow and Stewart, 1999).  
Early EM studies showed that the pentamer has a hole with a diameter of 30 Å 
centered at the five fold axis (Stewart et al., 1991; Stewart et al., 1993) that fits the 
anchoring peptide of the fiber knob. Two crystal structures of the Ad2 penton 
base were solved in 2005 (Zubieta et al., 2005) (Figure 3), one of just the penton 
base, and a second of the penton base in complex with the conserved 
anchoring peptide of a fiber knob (Zubieta et al., 2005). The penton base has a 
fold similar to the hexon, with the stable jelly-roll  -barrel domain forming the 
base and loop extensions. Sequence comparisons among the pentons have 
shown large diversity in the surface-exposed loops containing the RGD motif, 
possibly determining the tropism of the different types (Madisch et al., 2007). The 
penton base is also involved in the agglutination of erythrocytes, one of the 
criteria for grouping the Ads (A-F) (Wadell and Norrby, 1969). 
 
 
Figure 3. Cartoon representation of the Ad2 penton base (PDB accession number 1X9P). 
Each chain is colored differently. The view is along the five fold axis, looking down onto 
the particle. The hydrophobic N-terminal tail of the fiber protein is inserted into the large 
hole at the center. Figure made in PyMOL (DeLano, 2002). 
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1.4.3 Fiber (polypeptide IV) 
The trimeric fiber protein is inserted into the penton base and protrudes from 
each of the 12 vertices of the adenovirus capsid. Its structure can be divided into 
three domains: the N-terminal tail, anchoring the protein to the penton base, the 
shaft, and the C-terminal knob. A wide variation of the number of repeats 
(repetitive amino acids in the sequence) in the shaft is observed, ranging from 6 
in Ad3 to 22 in Ad5, probably influencing the viral tropism (Green et al., 1983). 
The first knob structure to be solved was that of Ad5 in 1994 (Xia et al., 1994). The 
crystal structure confirmed stoichiometric analyses indicating that the fiber is a 
homotrimeric protein (van Oostrum and Burnett, 1985). The result was 
controversial due to the symmetry mismatch as the trimeric fiber is positioned on 
a five fold rotation axis. With the crystal structure of the fiber knob (Xia et al., 
1994) it became clear why the knob was never seen in early EM constructions. 
One reason for this is that five fold symmetry averaging was employed to 
produce the density maps for the virions. Since the trimers do not have five fold 
symmetry, they were averaged out of the images (Stewart et al., 1991). Although 
the penton and the hexon also contain an eight-stranded   barrel fold forming 
the core of the protein, the topologies of the   barrels differ from that of the fiber 
(Figure 4). In additional the knob barrels have much shorter and less flexible 
loops. Several knob structures have been solved from almost all species (species 
A: Ad12, Species B: Ad3, Ad11 and Ad35, species C: Ad2 and Ad5, Species D: 
Ad19 and Ad37, Species F: Ad41) (Bewley et al., 1999; Burmeister et al., 2004; 
Durmort et al., 2001; Persson et al., 2007; Seiradake and Cusack, 2005; van Raaij 
et al., 1999a; Wang et al., 2007). Moreover, the structure of the canine Ad2 knob 
(Seiradake et al., 2006) is also known.  
The overall structures of all crystallized knobs are similar, but they differ 
in the loop areas determining receptor specificity (Bewley et al., 1999; Cusack, 
2005; Persson et al., 2007). Moreover, the overall fold is also similar to the reovirus 
attachment protein  1 (Chappell et al., 2002), which allows swapping of fibers 
between reovirus and adenovirus (Mercier et al., 2004). A single crystal structure 
of a fiber shaft of Ad2 has been successfully solved. The Ad2 structure contains 
four repeats of the shaft and is the only structural information available on that 
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region of the fiber (van Raaij et al., 1999b). The repeats have a novel triple beta 
spiral fold with a unique helical packing, explaining the repetitive pattern of 
glycine, proline and hydrophobic residues in the sequence. Interestingly, this fold 
is also shared with the reovirus attachment protein  1. Knob-less viruses can be 
constructed but leak DNA and are less stable, indicating that the fiber protein 
has an important role in stability (Schoehn et al., 1996; Von Seggern et al., 1999). 
 
Figure 4. Cartoon/surface representation of the Ad2 trimer (PDB accession number 1QIU). 
The protomers are shown in green, blue and orange. (A) Top view along the three fold 
axis. (B) Side view of the same trimer, showing four repeats of the adenovirus shaft. 
Figures made in PyMOL (DeLano, 2002). 
 
1.5 Adenoviruses and the host 
Ads normally enter the host through the mouth or the ocular conjunctiva. Some 
types, especially species C Ads, can be latent in young children and be shed 
(sporadic release of viral particles) for months, spreading through the fecal-oral 
route. The virus normally manifests locally in the eyes and pharynx before 
migration to the primary tissue, which is the optimal tissue for replication. This 
suggests that viral particles are present in the blood stream at some stage, i.e. 
the virus is viremic. 
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1.6 The Adenovirus life cycle 
The process of passing the membrane is called internalization, or penetration, of 
the virus particle. For this process much more is known for enveloped viruses than 
non-enveloped viruses. Enveloped viruses enter cells by membrane fusion, 
whereas non-enveloped viruses use membrane lysis or pore formation (Marsh 
and Helenius, 2006). For Ads the uptake of the viral particle is a stepwise process 
that differs depending on Ad type and receptor usage (Figure 5). In short, the first 
step is the primary interaction between the cellular receptor and the fiber 
protein of the virus capsid, associating the capsid with the cell surface. The 
primary attachment receptor is mostly an “anchoring event”. Next, the penton 
base interacts with integrins. This triggers uptake by clathrin mediated 
endocytosis and the transport of incoming viruses together with their receptors 
into early and late endosomes (Marsh and Helenius, 2006). The uptake is followed 
by dismantling of the capsid and endosomal escape (early endosome for 
species C Ads and late endosome for non-species C Ads) (Miyazawa et al., 
2001). Several proteins have been suggested for triggering the escape (penton 
base, fiber knob, protease and polypeptide VI) (Medina-Kauwe, 2003; Vellinga 
et al., 2005). As the endosome maturates and pH drops, the capsid proteins 
change conformation and the partially degraded particle penetrates the 
membrane (Seth 1985, Greber 1993). Before docking to the nuclear membrane 
and injection of viral DNA, the virus relocates from the endosome to the nucleus 
by bidirectional movement along microtubule. The mechanism of importing the 
adenovirus DNA is a Ca2+ dependent process (Greber et al., 1997). Additionally, 
the role of the non-structural adenovirus protease in degrading the capsid at 
NPC is of importance. After replication in the nucleus, the virus is released by 
inducing cell lysis. 
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Figure 5. Schematic drawing of the internalization of an Adenovirus particle.  Primary high 
affinity interaction with CD46 or CAR docks the virus to the cell surface. The binding event 
allows secondary interactions with integrins that trigger uptake by clathrin coated 
endocytosis. In the early endosome (species C, e.g. Ad5, blue circle), or late endosome 
(species B, e.g. Ad7, red circle), the particles escape due to altered conformation of 
structural proteins triggered by the drop in pH. The particles are engaged in bi-directional 
movement along microtubules and dock at the NPC, where the DNA is injected. 
 
1.7 The Adenovirus receptors 
The first step in a virus life cycle is the attachment to a cellular receptor 
prior to internalization of the capsid (Marsh and Helenius, 2006). The primary 
interaction can range from high- (Kirby et al., 1999; Persson et al., 2007) to low 
interaction (Burmeister et al., 2004; Neu et al., 2008) affinity. Viruses normally 
attach to a protein on the cell surface but also carbohydrates, and very 
occasionally lipids, are used (Dimmock, 2007). The receptor usage often, but not 
always, determines the host range, as well as the tropism of the virus. This explains 
why virus replication is limited to a certain type of tissue, even though the primary 
attachment receptor may be present on many cells (Flint, 2004). For Ads three 
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receptors have been confirmed; CAR, α2,3 linked sialic acid, and CD46. 
However, two more receptors are currently being investigated, CD80/CD86 
(Short et al., 2004; Short et al., 2006) and the unknown “receptor X” (Tuve et al., 
2006). The consequences for the adenovirus biology by using CD80/CD86 and 
“receptor X” are not clear, and more data is required for an understanding of 
the attachment processes with these proteins. 
1.7.1 The Coxsackie Adenovirus Receptor (CAR) 
Many Ads from different groups attach to cells by engaging the coxsackie- and 
adenovirus receptor (CAR), a member of the immunoglobulin superfamily and a 
component of tight junctions (Cohen et al., 2001). CAR is a 46 kDa homodimeric 
protein that functions primarily as the receptor for species A, C, D, E and F 
(Carson, 2001).  Sequence analysis indicates a single membrane spanning 
domain dividing the 107 amino acid long cytoplasmic tail from the 216 amino 
acids in the extracellular domain. CAR is located on the basolateral surface of 
cells in the respiratory tract, where, surprisingly, it is inaccessible to viruses. Ad 
infections can only occur after a transient break of the epithelia, exposing the 
CAR dimer (Flint, 2004). A structural basis for the interaction between Ad12 
(species A adenoviruses) and CAR (truncated version with one of the two 
domains, D1) was published in 1999 (Bewley et al., 1999) (Figure 6). In the 
structure, the main binding site on the adenovirus knob was located in the AB-
loop, with several water-filled cavities and multiple water molecules bridging 
interactions. Three structures of the interaction between Ads and CAR are known 
(Bewley et al., 1999; Seiradake et al., 2006), one of them with canine Ad type 2 
(Seiradake et al., 2006). In all structures, the knob engages the CAR-D1 protein in 
a similar fashion and binds with a very similar affinity, which is in the range of 15 
nM (Kirby et al., 2000; Wickham et al., 1993). 
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Figure 6. Cartoon representation of the Ad12 knob in complex with the N-terminal 
domain of CAR (CAR-D1) (PDB accession number 1KAC). The Ad12 knob shown in blue 
and CAR-D1 is in yellow. The view is along the three fold rotation axis, looking down the 
fiber. Figure made in PyMOL (DeLano, 2002). 
 
1.7.2 Sialic acid 
Sialic acid, (N-acetyl-neuraminic-acid) is widely expressed on animal tissues, and 
is normally found in glycoproteins and gangliosides (Angata and Varki, 2002; 
Varki, 2007). A small group of species D adenoviruses (Ad9, Ad19 and Ad37), 
causing primarily EKC, have been shown to use α2-3 linked sialic acid for cellular 
attachment, as opposed to CAR (Arnberg et al., 2000a; Arnberg et al., 2002a; 
Arnberg et al., 2000b; Arnberg et al., 2002b). They all bind CAR (Kirby et al., 2001; 
Seiradake et al., 2006), but sialic acid offers a more effective infectious route. 
These three knobs have a particularly positive surface at physiological pH, in 
comparison to Ads causing mild ocular infections or respiratory infections, 
allowing interactions with sialic acid in a charge dependent matter (Arnberg et 
al., 2002a).  
 The crystal structures of Ad37 and Ad19 (species D Ads) in complex with 
α2-3 sialyl lactose have been solved, providing a structural basis for the 
adenovirus-sialic acid interaction (Burmeister et al., 2004) (Figure 7). The binding 
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epitope is located at the positively charged top of the trimer, binding three 
copies of α2-3 sialyl lactose molecules used as receptor analogs. A correlation 
between shaft length and sialic acid binding has been proposed (Wu et al., 
2003).  
 
Figure 7. Surface representation (contact surface calculated with a 1.4 Å probe) of the 
Ad37 knob in complex with α2-3 sialyl lactose (PDB accession number 1UXA). The three 
chains of the Ad knob are shown in green, blue and red. The α2-3 sialyl lactose is 
represented with a stick model. The view is along the three fold rotation axis looking 
down the fiber. Figure made in PyMOL (DeLano, 2002). 
1.7.3 Membrane cofactor protein (MCP or CD46) 
CD46 (MCP) is a key component in the alternate pathway of the innate immune 
system where it protects self tissue against complement activation. CD46 was 
discovered when searching for C3b and C4b proteins of peripheral blood cells 
and was co-purified using affinity chromatography with CD35 (complement 
receptor 1) and CD21 (complement receptor 2) (Liszewski et al., 2005). CD46 was 
later found to inhibit complement activation by binding separately to C3b or 
C4b and stabilizing them for proteolytic cleavage by factor I, a plasma protein in 
the trypsin protease family (Liszewski et al., 1991). Inactivation of C3b and C4b 
inhibits continued complement activation and thus the formation of the 
membrane attack complex (Liszewski et al., 1996). CD46 provides an intrinsic 
defense in that it protects cells on whose surface it is expressed. Its broad tissue 
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distribution is accounted for by the necessity of guarding any cells that may be 
exposed to complement from its inappropriate activation. CD46 is expressed in 
four different isoforms generated by alternative splicing (BC1, BC2, C1 or C2) 
(Post et al., 1991; Riley-Vargas et al., 2004; Russell, 2004). All share the same 
extracellular portion. CD46 contains four short consensus repeat (SCR or CCP) 
modules, containing one N-linked glycosylation site each in SCR1 and SCR2, and 
one predicted in SCR4. In 1999, the crystal structure of the N-terminal two repeats 
of CD46 was published (Casasnovas et al., 1999) (Figure 8). The SCR1-SCR2 chain 
folds into two compact β-barrels, each containing a four stranded antiparallel β-
sheet. N-linked glycans are attached to Asn49 and Asn80. The glycans cover the 
majority of one side of the molecule, facing each other and stabilizing a distinct 
60° bend between SCR1 and SCR2. Following the four SCRs, a 25 amino acid 
sequence rich in serine, threonine and proline residues (the STP region) is present. 
This region is targeted for alternative splicing. Even though three exons (A, B and 
C) code for the STP region, expression occurs exclusively from exons B + C or C 
alone (Liszewski et al., 2005). The STP region contains several possible sites for O-
linked glycosylation. Following the transmembrane region is a short C-terminal 
cytoplasmic tail containing one of two possible sequences, CYT-1 or CYT-2, that 
are linked to cell signalling (Liszewski et al., 2005). The role of CD46 in cell 
signalling is not well characterized, however crosslinking of CD46 using DLG4, a 
scaffold protein important for neural signalling, altered the polarization of human 
epithelial cells (Ludford-Menting et al., 2002). Increasing amounts of data 
regarding CD46 and immune signalling have suggested that CD46 provides a 
link between innate and acquired immune function, possibly by influencing 
immune cell signalling and antigen processing (Elward et al., 2005; Russell, 2004).  
 In addition to species B Ads, measles virus, human herpes virus 6, group A 
Streptococcus pyogenes, Neisseria gonorrhoeae, and Neisseria meningitidis 
have all been found to utilize CD46 as a specific cellular receptor (Cattaneo, 
2004; Gaggar et al., 2003; Giannakis et al., 2002; Gill and Atkinson, 2004; 
Greenstone et al., 2002; Kirchner et al., 2005; Marttila et al., 2005; Santoro et al., 
1999; Segerman et al., 2003a; Segerman et al., 2003b; Segerman et al., 2006).  
Some of these pathogens only use CD46 for cellular entry, but others also alter 
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expression and signalling, thus affecting immune response against the pathogen 
(Cardoso et al., 1995; Gerlier et al., 1994). Taken together, these pathogens 
contribute significantly to morbidity and mortality all over the world, and CD46 is 
therefore sometimes referred to as a “pathogen magnet” (Liszewski et al., 2005). 
 
Figure 8. Cartoon representation of CD46 
SCR1-SCR2, with the glycans displayed as 
red stick models and disulfide bonds as 
yellow sticks (PDB accession number 1CKL). 
Figure modified from Casasnovas et al., 
1999. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.7.4 The role of integrins as entry receptors 
Integrins are an important family of cell adhesion proteins involved in cell 
migration and signalling (Hynes, 2002).  These proteins are large heterodimers 
composed of α and β subunits, making transmembrane connections to the 
cytoskeleton and activating several signalling pathways (Nemerow and Stewart, 
1999; Ruoslahti, 1997; Xiong et al., 2001). There at least 24 members of the integrin 
family, divided into four groups, and they bind different receptors as diverse as 
the Leukocyte specific receptor, Laminin receptor, Collagen receptors and 
receptors containing RGD motifs (Hynes, 2002). Integrins are co-receptors for Ads, 
and interactions between the penton base and integrins activates, among 
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others, phosphatidylinositol 3-kinase, Rac and Cdc42, resulting in the 
polymerization of actin- and clathrin-mediated endocytosis (Li et al., 1998a; Li et 
al., 1998b; Marsh and Helenius, 2006; Nemerow and Stewart, 1999). Several Ads 
have been shown to use integrins αvβ5 or αvβ3 for internalization (Greber, 2002; Li 
et al., 1998b; Nemerow and Stewart, 1999). However, some reports indicate that 
αvβ1 might also promote internalization due to its high expression levels on certain 
tumor cells (Li et al., 2001). In addition integrins α3β1, α5β1 , αMβ2, and  αLβ1 have also 
been implicated in Ad entry (Davison et al., 1997; Salone et al., 2003); Huang 
1996).  
 The penton base RGD-motif (Zubieta et al., 2005) interacts with integrins 
αvβ5 and/or αvβ3, probably at the interface between the α and β subunits, as 
indicated by the αvβ3 structure in complex with a cyclic RGD-peptide (Xiong et 
al., 2001). This interaction is thought to trigger clathrin coated endocytosis. Cryo-
EM images of the penton base show a protruding loop with a high flexibility that 
turned out to contain the RGD motif (Stewart et al., 1991). Unfortunately, in the X-
ray structure of the Ad2 penton base, the RGD motif can not be seen due to 
high flexibility (Zubieta et al., 2005).  Mutation or deletion of the RGD motif delays 
the uptake of the viral particle (Bai et al., 1993), as well as producing an impaired 
endosomal escape for members of several species (Shayakhmetov et al., 2004).  
1.8 Species B Adenoviruses 
The species B Adenoviruses are further divided into species B:1 (Ad3, Ad7, Ad16, 
Ad21, Ad50) and B:2 (Ad11, Ad14, Ad34, Ad35) according to their tropism. 
Species B:1 Ads mainly cause eye infections and respiratory tract infections, but 
also systemic infections and diarrhea. Species B:2 Ads primarily cause persistent 
infections of the urinary tract and kidneys, rarely causing eye and respiratory 
infections, and they are potentially lethal in immunocompromised hosts (Leen 
and Rooney, 2005; Levy et al., 1990). Ad3 and Ad7 cause infections in humans 
more frequently than the other species B adenoviruses, and neutralizing 
antibodies against these two are thus found in an overall higher percentage in 
humans (Metzgar et al., 2005; Vogels et al., 2003). Some species B adenoviruses 
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(Ad3, Ad7, Ad14, Ad16 and Ad21) are weakly oncogenic, causing tumors in a 
small proportion of hamsters after 4-18 months (Fujinaga and Green, 1967).  
The receptor usage of species B adenoviruses is not completely clear but 
CD46 has been shown to be a major receptor for most adenoviruses in this group 
(Gaggar et al., 2003; Segerman et al., 2003a; Segerman et al., 2003b; Sirena et 
al., 2004).  Ad7 and Ad3 can infect BHK cells when they are transfected with 
human CD46, as well as CD46-expressing A549 cells (Fleischli et al., 2007; Fleischli 
et al., 2005). Other studies have found that Ad3 and Ad7 do not use CD46 as a 
receptor (Marttila et al., 2005). In addition, a second group B receptor has 
recently been identified on human stem and tumor cells. This receptor is thought 
to be used by Ad7 and Ad14, but not by the closely related Ad11 (Tuve et al., 
2006). The picture is further complicated by data showing that the group D Ad37 
appears to bind CD46 in a calcium-dependent manner (Wu et al., 2004). In this 
case, binding of Ad37 to CD46 could be blocked with an antibody raised 
against the N-terminal 19 residues of CD46 (Wu et al., 2004).  
1.9 Clinical relevance  
1.9.1 Gene therapy 
Gene therapy is used to introduce new genes into cells, often for the purpose of 
treating disease or in order to restore or add gene expression. However, the 
delivery of a gene does not necessarily have to complement a deficiency, but 
can also specifically introduce a toxic compound, trigger an immune response, 
or lead to apoptosis of specific cell types (i.e. cancer cells) (Gardlik et al., 2005). 
There are two forms of viruses commonly used in gene therapy trials; (i) Non-lytic 
viruses, including retroviruses and lentiviruses, which leave the host cell intact by 
budding off the cellular membrane and (ii) lytic viruses, including adenoviruses 
and human herpes simplex virus, which leave the cell by lysis (Bangari and Mittal, 
2006b; Gardlik et al., 2005). As the adenovirus particle is particularly well studied 
and its transgene will remain episomal, this virus has become especially useful as 
a tool in gene therapy. Ad vectors are easily propagated to high titers, can be 
modified without difficulty, and have high transduction efficiency (Ritter et al., 
2002). The use of a primary and secondary receptor offers several modes of 
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altering cellular tropism (Wickham, 2003), by modifying the penton (Einfeld et al., 
1999), hexon (Vigne et al., 1999) or fiber (Michael et al., 1995; Wickham et al., 
1997). The first generation of Ad vectors was replication deficient, due to the 
insertion in the E1 region, and caused a notable immune response in two steps. 
The response was first against the injected virions, the second one against the 
newly synthesized proteins in the host cell. The second generation of vectors 
contained additional deletions in the E2 and E4 genes. However, a longterm 
expression that does not lead to CPE has not yet been achieved. The newest 
generations of Ad vectors, called “gutless vectors”, contain only cis-acting 
terminal repeats and lead to a very limited immune response. Unfortunately, 
these vectors can only replicate when complemented (Gardlik et al., 2005).  
Most gene delivery studies involving Ad vectors have been performed 
using the CAR binding Ad5. The current challenge is to obtain high gene delivery 
in cell types expressing low levels, or no, CAR at all. Among these cell types are 
many advanced tumor cells, skeletal muscle cells, smooth muscle cells, 
peripheral blood cells, hematopoietic stem cells and dendritic cells (Mizuguchi 
and Hayakawa, 2004). However, new strategies for improving the low 
transduction rate in some cell lines include the insertion of an RGD-motif in the HI- 
or IJ-loop of the fiber protein (Borovjagin et al., 2005). Retargeting experiments of 
Ad5 vectors inserting a RGD motif in the HI-loop increased the transduction of 
esophageal cancer cell lines up to 800 fold (Buskens et al., 2003). Since the 
discovery of CD46 as a cellular receptor for species B adenoviruses, two vectors 
based on CD46 binding serotypes (Ad11 and Ad35) have been tested (Brouwer 
et al., 2007; Stone et al., 2005). These vectors have the benefit of lower pre-
existing immunity (Bangari and Mittal, 2006a) in comparison to Ad5. Furthermore, 
CD46 is ubiquitously expressed, which allows transduction of cells expressing low 
levels of CAR. So far, no studies have reported a cross reactivity of neutralizing 
antibodies against Ad11, and Ad35, which allows for immunization without an 
increased immune response (Holterman et al., 2004). Observed down-regulation 
of CD46 has implications for gene delivery using the species B adenoviruses 
(Larochelle et al., 2008).  
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1.9.2 Vaccination and treatment 
Over the last decades, up to 80% of new military recruits in the U.S have acquired 
lower respiratory tract infections during the first three weeks of training, and 20% 
of these needed to be hospitalized. The most common diagnosis, in 60% of the 
cases, is an Ad4 infection followed by Ad7 infection (Xu and Erdman, 2001). 
However, this also led in 1971 to a vaccination program of new recruits using a 
live encapsulated enteric vaccine, first for Ad4 but later also for Ad7. The 
program was abandoned in 1999 due to economical reasons (Metzgar et al., 
2007). Very recent outbreaks of severe upper respiratory tract infections caused 
by Ad14 and Ad21, with fatal outcome in healthy individuals, have renewed 
interest in vaccination, interestingly against Ad4 and Ad7 (Metzgar et al., 2007). 
Earlier vaccinations probably also allowed protection against Ad14, by cross 
reactivity between Ad7 and Ad14, due to the very high homology (CDC, 2007; 
Metzgar et al., 2007), thus protecting against both Ad7 and Ad14. A new 
effective vaccination program for the U.S army is therefore anticipated by 2008 
(Russell et al., 2006).  
CD46 binding Ads have long been implicated in the pathogenesis of 
disease that occurs in the peri-transplant period, including severe nephritis with 
graft loss, hemorrhagic cystitis, hemophagocytic syndrome, and fatal multi-organ 
system infections (Akiyama et al., 2001; Levy et al., 1990; Liles et al., 1993). 
However, recent Ad infections with a lethal outcome of normal healthy 
individuals are very alarming and indicate that Ads could become a larger 
problem in the future, underscoring the need for an effective treatment, and 
possibly vaccination. 
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1.10 Aim 
The overall aim of this work was to provide a structural basis for the attachment 
of Ads to the human CD46 protein, which functions as the cellular receptor for 
several pathogenic Ads. We designed a combination of structural and functional 
analyses in order to determine the requirements for a functional interaction of Ad 
knobs with CD46. Key questions to be answered by our research were: What 
defines the Ad epitope necessary for a productive interaction with CD46? Which 
region of CD46 is recognized by Ad knobs? Are there structural rearrangements 
in either protein upon complex formation? Do different CD46-binding Ad knobs 
differ in their interaction with the receptor, either at the structural level, or in their 
relative affinities? Can one engineer Ad knob mutations with altered CD46-
binding properties? Does the Ad knob binding site for CD46 overlap with 
previously known ligands for Ad knobs? Does CD46 engage Ads with a region 
also involved in physiologic interactions?  
Answering these questions will help to provide a foundation for the 
rational design of drugs that might prevent infections of Ads that interact with 
CD46. Moreover, these studies were also thought to have implications for gene 
therapy, since it is desirable to limit the distribution of some Ad type vectors by 
focusing transduction to cell-, organ- or tissue specific molecules. Such strategies 
could potentially be explored by subtly modifying the interaction with CD46 in 
order to retarget Ad vectors for treatment of cancer, hereditary disorders and 
infectious diseases. Knowledge about the precise mechanism of interaction 
between the virus and its receptor is essential to perform such studies. 
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2 Materials 
2.1 Equipment 
2.1.1 General purpose equipment 
Autoclave V95 Systec, Wettenberg, Germany 
Shaker Intelli-Mixer NeoLab®, Heidelberg, Germany 
Icemaker Scotsman, Milan, Italy 
Gel dryer Slab 2300 LKB, Bromma, Sweden 
Microwave NN-E203 WB Panasonic, Hamburg, Germany 
Mini Protean 3 Cell Bio-Rad, Munich, Germany 
Mini Sub-Cell GT Bio-Rad, Munich, Germany 
Shaker Dos-10L NeoLab®, Heidelberg, Germany 
PCR-Cycler iCycler Bio-Rad, Munich, Germany 
pH-Meter PB-11 Sartorius, Göttingen, Germany 
Photometer SmartSpecTM Plus Bio-Rad, Munich, Germany 
Pipette Mettler (2.5 µl) Mettler Toledo, Columbus, USA 
Pipettes Pipetman Gilson, Middleton, USA 
PowerPac Basic Bio-Rad, Munich, Germany 
Quartz Cuvette (75 µl) Helma, Jena, Germany 
SpeedVac Heto Vacuum Centrifuge Heto, Allerod, Denmark 
Thermoshaker Unitron InforsHT, Bottmingen, Switzerland 
Transilluminator Universal Hood II Bio-Rad, Munich, Germany 
Scale 323S-OCE Sartorius, Göttingen, Germany 
Scale 4202S-OCE Sartorius, Göttingen, Germany 
Scale Genius Sartorius, Göttingen, Germany 
Centrifuge 5414D Eppendorf, Wesseling-Bertzdorf, Germany 
Centrifuge J2-21 Beckman, Langenselbold, Germany 
Centrifuge Multifuge 1L-R Kendro, Langenselbold, Germany 
Centrifuge Sorvall RC-6 Kendro, Langenselbold, Germany 
Sorvall Rotor SS34 Kendro, Langenselbold, Germany 
Sorvall Rotor SLC4000 Kendro, Langenselbold, Germany 
Sorvall Rotor 75002000 Kendro, Langenselbold, Germany 
Hera Cell 240 incubator Thermo Scientific, South Logan, USA 
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2.1.2  Chromatography 
Analytical FPLC Smart GE Healthcare, Uppsala, Sweden 
FPLC BioLogic Duo Flow Bio-Rad, Munich, Germany 
FPLC GE Healthcare GE Healthcare, Uppsala, Sweden 
HisTrap column HP 1 ml GE Healthcare, Uppsala, Sweden 
Concanavalin A Sepharose GE Healthcare, Uppsala, Sweden 
Gelfiltration column Superdex® 200 HiLoad 
(16/60) 
GE Healthcare, Uppsala, Sweden 
Gel filtration column Superdex® 200 HR 2ml GE Healthcare, Uppsala, Sweden 
Gel filtration column Superdex® 200 HR 
(10/30) 
GE Healthcare, Uppsala, Sweden 
Ion Exchange column MonoQ 5/50 GE Healthcare, Uppsala, Sweden 
Homogenizer EmulsiFlex®-C3 Avestin, Ottawa, Canada 
Sonicator Digital Sonifier 250 Branson, Danbury, USA 
Peristaltic pump Econo Pump Bio-Rad, Munich, Germany 
UV Detector Uvicord SII GE Healthcare, Uppsala, Sweden 
2.1.3  X-ray crystallography equipment 
Cryosystem X-Stream Rigaku/MSC, The Woodlands, USA 
Detector MAR 345 dtb Mar research, Hamburg, Germany 
Rotating Anode Micromax 007 HF Rigaku/MSC, The Woodlands, USA 
Digital Microscope with polarization filter 
MZ16 
Leica, Wetzlar, Germany 
Microscope S6E Leica, Wetzlar, Germany 
Optics Varimax HF Rigaku/MSC, The Woodlands, USA 
Detector MAR ccd 225 Mar research, Hamburg, Germany 
Detector ADSC Q315 Area detector systems corporation, 
Poway, USA 
Pilatus pixel detector Swiss Light Source, Villigen, Switzerland 
Depression wells Hampton research, Aliso Viejo, USA 
Fiber loops/ magnetic bases Hampton research, Aliso Viejo, USA 
96 well crystallization plates Art Robbins, Sunnyvale, USA 
24 well crystallization plates Hampton research, Aliso Viejo, USA 
22mm siliconized cover slides Hampton research, Aliso Viejo, USA 
2.1.4 Software 
CCP4 CCP4, 1994 
CNSsolve Brunger et al., 1998 
Coot Emsley et al., 2004 
HKL package HKL research Inc., Charlottesville, USA 
Mar345dtb Mar research, Hamburg, Germany 
PyMOL DeLano, 2002 
Ribbons Carson, 1997 
GRASP Nicholls et al., 1991 
RAVE package Kleywegt et al., 2001 
XDS package Kabsch, 1993 
Origin 7.0 plus ITC MicroCal, Milton Keynes, United Kingdom 
Excel Microsoft, Washington, USA 
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2.1.5 Filters and kits 
0.45 µm Nitrocellulose membrane Millipore, Schwabach, Germany 
Amicon Ulra 4 Concentrator Millipore, Schwabach, Germany 
Amicon Ultra 15 Concentrator Millipore, Schwabach, Germany 
Centricon Plus-70 Concentrator Millipore, Schwabach, Germany 
PCR purification kit Qiagen, Hilden, Germany 
Promega Miniprep kit Promega, Mannheim, Germany 
2.2 Cloning and expression 
2.2.1 Bacterial strains 
Strain Genotype Company 
DH5α fhuA2  (argF-lacZ)U169 phoA 
glnV44  80  (lacZ)M15 gyrA96 
recA1 relA1 endA1 thi-1 hsdR17  
Personal stock from 
Prof. Dr. Stehle 
Nova Blue endA1 hsdR17 (rK12– mK12+) supE44 
thi-1 recA1 gyrA96 relA1 lac 
F [proA+B+ lacIqZΔM15::Tn10] (TetR) 
Merck (Novagen), 
Darmstadt, 
Germany 
Rosetta 2 (DE3) F- ompT hsdSB(rB- mB-) gal dcm 
(DE3) pRARE2 (CamR) 
Merck (Novagen), 
Darmstadt, 
Germany 
2.2.2 Eukaryotic cell lines 
CHO Lec 3.2.8.1 (Stanley, 1989) 
A549 (University of Umeå) 
2.2.3 Bacterial expression plasmid 
For all bacterial expression the pET-15b plasmid (gene map at: 
www.merckbiosciences.co.uk) (Merck (Novagen), Darmstadt, Germany) was 
used. 
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2.2.4 CHO cell expression plasmid 
The CHO-cells were transfected using the pBJ5-GS plasmid (Lonza, Basel 
Switzerland) 
 
Figure 9. Gene map of the pBJ5-GS plasmid (Figure 
obtained from www.its.caltech.edu). 
 
 
 
 
 
 
 
 
 
 
 
2.2.5 PCR-reactions 
Pfu-ultra (Stratagene, La Jolla, Canada) 
10x Pfu-ultra buffer (Stratagene, La Jolla, Canada) 
TaqLC-polymerase (Fermentas, St. Leon-Rot, Germany) 
10X buffer –MgCl2 +(NH4)2SO4 (Fermentas, St. Leon-Rot, Germany) 
2.2.6 Primers 
For all Ad knob constructs the following primers were used. The amino acid 
numbers cloned into the construct are given in parenthesis. The restriction 
recognition sequence is underlined. The oligo nucleotides were ordered from 
Biomers (Ulm, Germany).  
 
Primers for wt proteins 
Construct (amino acid number) Primer sequence 5’-3’ 
Ad11 (118-325) Fw-Nde1 GGGAATTCCATATGGGACTTACATTCAATTCAAACAACAT 
Ad11 (118-325) Rev-BamH1 TGGTATGGATCCTCAGTCGTCTTCTCTGATGTAGTAAAA 
Ad7 (118-325) Fw-Nde1 GGAATTCCATATGTTGGGAGAAGGACTTACATTC 
Ad7 (118-325) Rev-BamH1 TGGTATGGATCCTCAGTCGTCTTCTCTAATG 
Ad14 (123-325) Fw-Nde1 GGGAATTCCATATGAACAACATTTGCATTGATGECAAT 
Ad14 (123-325) Rev-BamH1 TGGTATGGATCCTCAGTCGTCTTCTCTGATGTAGTAAAA 
Ad35 (118-325) Fw-Nde1 GGGAATTCCATATGTTAAAATTTAACAACGGTGACATT  
Ad35 (118-325) Rev-BamH1 GTATGGATCCTTAGTTGTCGTCTTCTGTAATGTAAGA 
Ad35short (123-325) Fw-Nde1 GGGAATTCCATATGGGTGACATTTGTATAAAGGAT  
Ad35short (123-325) Rev-BamH1 GTATGGATCCTTAGTTGTCGTCTTCTGTAATGTAAGA 
Ad21 (118-325) Fw-Nde1 GGGAATTCCATATGTTAAAATTTAACAACGGTGACATT  
Ad21 (118-325) Rev-BamH1 TGGTATGGATCCTTAGTTGTCGTCTTCTCTAATATAAGA 
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Primers for mutant proteins (Mutation shaded in grey) 
Construct (amino acid number) Primer sequence 5’-3’ 
Ad11-N245S (118-325) Fw GCCTATCCTTTCTCCGATAATTCTAGAG 
Ad11-N245S (118-325) Rev CTCTAGAATTATCGGAGAAAGGATAGGC 
Ad11-R279Q (118-325) Fw ATGCTTAACCAGAGAGCAATAAAT 
Ad11-R279Q (118-325) Rev ATTTATTGCTCTCTGGTTAAGCGT 
Ad11-R279S (118-325) Fw ATGCTTAACTCTAGAGCAATAAAT 
Ad11-R279S (118-325) Rev ATTTATTGCTCTAGAGTTAAGCAT 
Ad11-R280G (118-325) Fw ATGCTTAACCGATCCGCAATAAAT 
Ad11-R280G (118-325) Rev ATTTATTGCGGATCGGTTAAGCAT 
Ad11-I282L (118-325) Fw AACCGAAGAGCACTTAATGACGAGACA 
Ad11-I282L (118-325) Rev TGTCTCGTCATTAAGTGCTCTTCGGTT 
Ad11-N283S (118-325) Fw CCGAAGAGCAATATCCGACGAGACATCATATT 
Ad11-N283S (118-325) Rev AATATGATGTCTCGTCGGATATTGCTCTTCGG 
Ad11-D284S (118-325) Fw CCGAAGAGCAATAAATTCCGAGACATCATATT 
Ad11-D284S (118-325) Rev AATATGATGTCTCGGAATTTATTGCTCTTCGG 
Ad7-Q279R (118-325) Fw CTGTCATGCTTAACCGAAGAGCATTAAATA 
Ad7-Q279R (118-325) Rev TATTTAATGCTCTTCGGTTAAGCATGACAG 
 
Sequencing primers 
Primer name Primer Sequence 5’-3’ 
T7 Promoter TAATACGACTCACTATAGGG 
T7 Terminator GCTAGTTATTGCTCAGCGG 
2.2.7 Restriction enzymes 
All restriction enzymes were obtained from Promega (Mannheim, Germany) and 
used in the supplied buffers. 
 
Restriction Enzyme Recognition sequence Digestion type Buffer 
BamH1 G GATC C 
C CTAG G 
Sticky end D 
Nde1 CA TA TG 
GT AT AC 
Sticky end D 
Xho1   C TCGA G 
G AGCT C 
Sticky end D 
2.2.8 Ligation of plasmids 
Shrimp Alkaline Phosphatase (SAP) (Fermentas, St. Leon-Rot, Germany) 
T4-DNA ligase (Fermentas, St. Leon-Rot, Germany) 
5x rapid ligation buffer (Fermentas, St. Leon-Rot, Germany) 
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2.3 Cell culture 
2.3.1 Bacterial expression 
LB medium for bacterial growth 
LB-Broth (Sigma, Munich, Germany) supplemented with 50 mM Ampicillin (Sigma, 
Munich, Germany) 
 
LB agar 
LB-Broth (Sigma, Munich, Germany) supplemented with 50 mM Ampicillin (Sigma, 
Munich, Germany)  
14 g Bacto-agar (Roth, Karlsruhe, Germany)/l LB-Broth 
 
Induction 
IPTG (Isopropyl  -D-thiogalactopyranoside) (Peqlab, Erlangen, Germany) 
2.3.2 CHO cell expression 
CHO cell culture medium  
5% Fetal Calf Serum (PAA, Cölbe, Germany) 
20 mM GS-supplement (PAA, Cölbe, Germany) 
5 mM Antibiotics (PEST) (PAA, Cölbe, Germany) 
750 µM HEPES (Roth, Karlsruhe, Germany) 
10 µM MSX (Sigma, Munich, Germany) 
 
Passage of cells 
Trypsin/EDTA (PAA, Cölbe, Germany) 
 
2.4 Protein chemistry 
2.4.1 DNA electrophoresis 
100 bp DNA Marker (Fermentas, St. Leon-Rot, Germany) 
Bacto Agar (Roth, Karlsruhe, Germany) 
2.4.2 SDS-PAGE 
10 x SDS Running buffer (Roth, Karlsruhe, Germany) 
1 M Glycine buffer pH 6.8 (Roth, Karlsruhe, Germany) 
1 M Glycine buffer pH 8.8 (Roth, Karlsruhe, Germany) 
APS (Roth, Karlsruhe, Germany) 
TEMED (Roth, Karlsruhe, Germany) 
Unstained protein marker (Fermentas, St. Leon-Rot, Germany) 
Comassie stain (Fluka, Steinheim, Germany) 
β-Mercapto-ethanol (Roth, Karlsruhe, Germany) 
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2.4.3 Concentration determination of protein 
Biorad Protein Assay (Bio-Rad, Munich, Germany) 
2.4.4 Deglycosylation 
EndoH (New England Biolabs, Ipswich, USA) 
2.5 SPR   
2.5.1 SPR buffers 
HBS-EP running buffer (CM5-Chip) 
10 mM HEPES pH 7.4 at 25 °C (Roth, Karlsruhe, Germany) 
150 mM NaCl (Roth, Karlsruhe, Germany) 
0.005 % v/v surfactant P20 (GE Healthcare, Uppsala, Sweden) 
3 mM EDTA (Sigma, Munich, Germany) 
 
HBS-P running buffer (Ni-Chip) 
10 mM HEPES pH 7.4 at 25 °C (Roth, Karlsruhe, Germany) 
150 mM NaCl (Roth, Karlsruhe, Germany) 
0.005 % v/v surfactant P20 (GE Healthcare, Uppsala, Sweden) 
50 mM EDTA (Sigma, Munich, Germany) 
 
HBS-P stripping buffer (Ni-Chip) 
10 mM HEPES pH 7.4 at 25 °C (Roth, Karlsruhe, Germany) 
150 mM NaCl (Roth, Karlsruhe, Germany) 
0.005 % v/v surfactant P20 (GE Healthcare, Uppsala, Sweden) 
350 mM EDTA (Sigma, Munich, Germany) 
 
Chip generation buffer 
HBS-P buffer 
5 mM NiCl2 (Sigma, Munich, Germany) 
2.5.2 BiaCore chips 
CM5 (GE Healthcare, Uppsala, Sweden) 
NiNTA (GE Healthcare, Uppsala, Sweden) 
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2.6 Crystallization 
2.6.1 Crystallization screens  
Screen Conditions Manufacturer Reference 
Wizard screens 1  
and 2 
192 Emerald BioScience, 
Bainbridge Island, 
USA 
---- 
---- 
Hampton screens  
1 and 2 
192 Hampton Research, 
Aliso Viejo, USA 
(Cudney et al., 1994; 
Jancarik and Kim, 1991) 
PEG/Ion screen 48 Hampton Research, 
Aliso Viejo, USA 
---- 
---- 
Hampton Lite 48 Hampton Research, 
Aliso Viejo, USA 
(Jancarik and Kim, 1991; 
McPherson, 1990) 
Additive screen 1 24 Hampton Research, 
Aliso Viejo, USA 
(Cudney et al., 1994; 
Sousa, 1995) 
2.6.2 Crystallization reagents 
Chemical Manufacturer  Chemical Manufacturer 
PEG200 Sigma, Munich, Germany /Fluka, 
Steinheim, Germany 
 CHES Sigma, Munich, 
Germany 
PEG400 Sigma, Munich, Germany /Fluka, 
Steinheim, Germany 
 Glycine Roth, Karlsruhe, 
Germany 
PEG600 Sigma, Munich, Germany /Fluka, 
Steinheim, Germany 
 Bicine Sigma, Munich, 
Germany 
PEG1000 Sigma, Munich, Germany /Fluka, 
Steinheim, Germany 
 MgCl2 Merck, Darmstadt, 
Germany 
PEG3350 Sigma, Munich, Germany /Fluka, 
Steinheim, Germany 
 Glycerol Sigma, Munich, 
Germany 
PEG6000 Sigma, Munich, Germany /Fluka, 
Steinheim, Germany 
 MPD Sigma, Munich, 
Germany 
PEG8000 Sigma, Munich, Germany /Fluka, 
Steinheim, Germany 
 Glucose Roth, Karlsruhe, 
Germany 
Sodium  
acetate 
Sigma, Munich, Germany  NaCl Roth, Karlsruhe, 
Germany 
Sodium  
phosphate 
Sigma, Munich, Germany  CaCl2 Merck, Darmstadt, 
Germany 
MES Sigma, Munich, Germany  ZnCl2 Fluka, Steinheim, 
Germany 
HEPES Roth, Karlsruhe, Germany  ZnSO4 Fluka, Steinheim, 
Germany 
TRIS Sigma, Munich, Germany 
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2.7 Buffers 
2.7.1 Generation of competent cells 
Tfb I 
100 mM RbCl (Sigma, Munich, Germany) 
10 mM CaCl2 (Merck, Darmstadt, Germany) 
50 mM MnCl2 (Sigma, Munich, Germany) 
30 mM K Acetate (Sigma, Munich, Germany) 
15% Glycerol (Sigma, Munich, Germany) 
 
Tfb II 
10 mM MOPS (Sigma, Munich, Germany) 
75 mM CaCl2 (Sigma, Munich, Germany) 
10 mM RbCl (Sigma, Munich, Germany) 
15% Glycerol (Sigma, Munich, Germany) 
2.7.2 Buffers protein purification 
Lysis buffer 
50 mM NaH2PO4 pH 8.0 (Sigma, Munich, Germany) 
20 mM Imidazole (Sigma, Munich, Germany) 
300 mM NaCl (Roth, Karlsruhe, Germany) 
 
His-Trap wash buffer 
50 mM NaH2PO4 pH 8.0 (Sigma, Munich, Germany) 
50 mM Imidazole (Sigma, Munich, Germany) 
500 mM NaCl (Roth, Karlsruhe, Germany) 
 
His-Trap elution buffer 
50 mM NaH2PO4 pH 8.0 (Sigma, Munich, Germany) 
300 mM Imidazole (Sigma, Munich, Germany) 
500 mM NaCl (Roth, Karlsruhe, Germany) 
 
Gel filtration buffer 
20 mM HEPES pH 7.4 (Roth, Karlsruhe, Germany) 
150 mM NaCl (Roth, Karlsruhe, Germany) 
 
Ion exchange buffer A 
20 mM HEPES pH 7.4 (Roth, Karlsruhe, Germany) 
 
Ion exchange buffer B 
20 mM HEPES pH 7.4 (Roth, Karlsruhe, Germany) 
1.0 M NaCl (Roth, Karlsruhe, Germany) 
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Con A Sepharose equilibration buffer 
20 mM HEPES pH 7.4 (Roth, Karlsruhe, Germany) 
500 mM NaCl (Roth, Karlsruhe, Germany) 
1 mM MgCl2 (Merck, Darmstadt, Germany) 
1 mM CaCl2 (Merck, Darmstadt, Germany) 
1 mM MnCl2 (Sigma, Munich, Germany) 
 
Con A Sepharose wash buffer 
20 mM HEPES pH 7.4 (Roth, Karlsruhe, Germany) 
1.0 M NaCl (Roth, Karlsruhe, Germany) 
1 mM CaCl2 (Sigma, Munich, Germany) 
1 mM MnCl2 (Sigma, Munich, Germany) 
 
Con A Sepharose elution buffer 
20 mM HEPES pH 7.4 (Roth, Karlsruhe, Germany) 
500 mM NaCl (Roth, Karlsruhe, Germany) 
12.5% w/v methyl- -D-mannopyranoside (Sigma, Munich, Germany) 
1 mM MgCl2 (Merck, Darmstadt, Germany) 
1 mM CaCl2 (Merck, Darmstadt, Germany) 
1 mM MnCl2 (Sigma, Munich, Germany) 
 
Con A Sepharose regeneration high pH buffer 
100 mM TRIS pH 8.5 (Sigma, Munich, Germany) 
500 mM NaCl (Roth, Karlsruhe, Germany) 
 
Con A Sepharose regeneration low pH buffer 
100 mM Citric acid pH 4.5 (Fluka, Steinheim, Germany) 
500 mM NaCl (Roth, Karlsruhe, Germany) 
 
Con A Sepharose regeneration storage buffer 
Acetate pH 6.0 (Sigma, Munich, Germany) 
1 M NaCl (Roth, Karlsruhe, Germany) 
1 mM MgCl2 (Merck, Darmstadt, Germany) 
1 mM CaCl2 (Merck, Darmstadt, Germany) 
1 mM MnCl2 (Sigma, Munich, Germany) 
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3 Methods 
3.1 Molecular biology 
3.1.1 Polymerase Chain Reaction (PCR) 
The PCR reaction (Mullis et al., 1986) was used for amplification of the fiber gene 
of several species B adenoviruses (Ad7, Ad11, Ad14, Ad21 and Ad35) (see 
Appendix). Primers for each PCR reaction were manually constructed fitting the 
type sequence obtained from Genebank (GenBank, 2008) (see Materials section 
2.2.6, Appendix 7.1).  In this thesis, more detailed information about the 
recombinantly expressed proteins can be found in the Appendix.  Several 
mutations were constructed by Overlap Extension PCR with the mutation 
introduced using a second set of primers. Briefly, the second sets of primers are 
constructed to contain a mismatch with the mutation at the center.  The 
mutation is then introduced in two steps (Figure 10) by generating half of each 
gene in separate test tubes (reaction A). The two halves are then fused in a 
second reaction B using the wt flanking primers (see Materials section 2.2.6). Both 
reactions were performed at optimal annealing temperature (5 °C below the 
primer melting temperature), using 10 pMol of primer and 100 ng of insert. For 
reaction B, 100 ng of each fragment was used. 
 
 
 
Figure 10. Overlap extension PCR. The mutation is introduced on a second set of primers 
in two PCR reactions. In reaction one primer pair 1+3 and 2+4 are used, in reaction two 
primer pair 1+4 generating an insert with mutation and flanking restriction enzyme cutting 
sequences.  
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3.1.2 Purification of plasmid DNA 
In this work, purification of amplified insert was performed using a PCR 
purification kit from Qiagen according to the manufacturer’s instructions. The 
amplified plasmids were purified by pelleting the plasmids ethanol at -80 ºC over 
night. All DNA concentrations were measured using absorbance at a UV 
wavelength of 260 nm (A260) or 280 nm (A280) with a spectrophotometric 
analysis. DNA bases absorb UV light at 260 nm. The concentration of pure 
double-stranded DNA at an A260 of 1.0 is 50 mg/ml. Since there is a linear 
relationship between absorbance and DNA concentration, the following formula 
can be used (Eq. 1): 
 
   Equation 1 
 
Aromatic amino acids in proteins absorb UV light at 280 nm. Thus, by dividing 
A260/A280 one gets a constant direct proportional to the protein contamination 
in the sample, i.e. an indication of DNA purity  
3.2 Restriction enzyme digestion and 
plasmid ligation 
3.2.1 Adenovirus knob 
The amplified insert was digested by double digestion using Promega enzymes in 
the appropriate supplied buffers, according to the manufacturer’s instructions (in 
all cases buffer D). After dephosphorylation using SAP, in buffer D, the linearized 
plasmid was mixed with a three fold excess of insert. Ligation was then 
performed using T4 DNA ligase (Fermentas), in rapid ligation buffer at 20 °C, 
according to the manufacturer’s protocol. The pET15-b vector was used, which 
contains a thrombin cleavable N-terminal hexahistidine tag. The plasmid was 
transformed into E. coli Nova Blue or E. coli DH5α cells using a heat shock 
protocol (incubation of 5 min on ice, 42 °C for 1 min, 5 min on ice), followed by 
incubation at 37 °C in LB medium without ampicillin (see Materials section 2.3.1). 
Amplified and purified plasmids were sequenced using the Value Read Package 
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service at MWG (Eurofins group, Germany) using the T7 Promoter and T7 
Terminator primers (see Materials section 2.2.6). 
3.2.2  Human CD46 
The stable cell lines used for expression of the two CD46 constructs were 
produced by Jose M. Casasnovas. cDNA coding for amino acids 35-160 (CD46 
SCR1-SCR2) or 35-288 (CD46 SCR1-SCR4) of human CD46 was cloned into the 
pBJ5-GS expression vector, which contains a glutamine synthetase enzyme for 
selection as described elsewhere (Bebbington et al., 1992; Casasnovas et al., 
1999). Stable transfectants were selected by increasing amounts of methionine 
sulfoxime. The cells have four independent mutations in the N- and O- 
glycosylation pathways (Stanley, 1989), resulting in N-linked carbohydrates of the 
high mannose type ranging from Man5 to Man9. O-glycosylation is homogenous, 
with only a single GalNAc residue attached per site.  
3.3 Protein chemistry 
3.3.1 Protein expression 
The expression of recombinant protein was driven by the LacZ promoter through 
addition of IPTG. IPTG is not hydrolyzable by the cell and is therefore kept at a 
constant concentration during the entire expression.  
3.3.1.1 Adenovirus knob 
E. coli Rosetta 2 (DE3) cells were transformed as described in the Methods 
section 3.2.1, and used for expression of all recombinant knobs. A glycerol stock 
was prepared for all constructs using 3 ml of an 8 hrs old culture, supplemented 
with 20% glycerol. During expression, the cells were grown at 37 ºC to an OD600 of 
0.6 and induced for 16 hrs at 20 ºC, using 1 mM of IPTG. The cells were then 
pelleted, using a Sorvall RC6 centrifuge and a SLC 4000 (Sorvall) rotor at 4000 g 
for 20 min, and resuspended in 10 ml lysis buffer, per liter of culture (see Materials 
section 2.7). The resuspended pellet was supplemented with 1 mM 
phenylmethylsulphonylfluoride (PMSF) for protease inhibition. The cells were lysed 
using a high pressure homogenizer (EmulsiFlex-C3). The lysate was cleared by 
centrifugation at 20.000 g using a SS34 rotor (Sorvall) for 90 min followed by 
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filtration of the supernatant through a 0.45 µm nitrocellulose filter membrane 
(Millipore). 
3.3.1.2  Human CD46 
The CHO-cells were grown in Ex-cellTM302 CHO serumfree medium (SAFC 
Biosciences) supplemented with 1x glutamine (50x stock, SAFC Biosciences), 5% 
Fetal Calf Serum (Gibco) and 1x Penicillin/Streptavidin (100X stock, PAA) (see 
Materials section 2.3.2). Cells from four 95% confluent 175 ml cell culture flasks 
were harvested using Trypsin/EDTA (1x stock PAA), pelleted at 2000 g, 
resuspended in 10 ml of fresh medium and then transferred to a roller bottle flask 
(Greiner) in 300 ml of medium. After three days, rotating at 37 ºC with 5% CO2 
(Hera Cell 240 incubator), the medium was replaced. Dead detached cells were 
removed by centrifugation at 4000 g for 10 min, and the collected cell 
supernatant frozen at -20 °C for storage. The cells in the roller bottles were 
discarded after 4 weeks of protein production.  
3.4 Protein purification 
All proteins were purified and stored at either 4 ºC, or if possible -80 ºC. Some 
mutants tended to precipitate upon freezing. 
3.4.1  Adenovirus knob purification 
The following purification procedure explains how the Ad11 knob was purified, 
but the very same protocol was used for all other knobs described in this thesis. 
Detailed information about buffers used here can be found in the Materials 
section 2.7 of this thesis. 
3.4.1.1  General – His-Trap chromatography 
Histidine-tagged (His-tagged) proteins have a high selective affinity for Ni2+ 
several divalent metal ions. Consequently, a protein containing a histidine tag 
binds strongly to a metal-ion charged medium while other cellular proteins bind 
only weakly. Histidine-tags are small and can therefore be less disruptive to the 
properties of the proteins to which they are attached. Elution is performed by 
competing out the interaction between the His-tag and the Ni2+ by increasing 
concentrations of imidazole.  
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3.4.1.2 Adenovirus knob purification – His-Trap chromatography 
The cleared supernatant was filtered through a 0.45 µm nitrocellulose membrane 
(Millipore) and applied to a Ni-charged 1 ml His-Trap HP column (Amersham 
Biosciences) for affinity purification at a flow rate of 1 ml/min using an ÄKTA™ 
system (GE Healthcare) at 4 °C.  After washing with 20 column volumes of His-
Trap wash buffer the protein was eluted using a 60 ml three step gradient at 20%, 
50% and 100% HisTrap elution buffer (e.g 100 mM imidazole, 250 mM imidazole 
and 500 mM imidazole) collecting 2 ml fractions.  
3.4.1.3  General - size exclusion chromatography 
Gel filtration is a useful technique for handling biomolecules that are sensitive to 
changes in pH, concentration of metal ions or co-factors and harsh 
environmental conditions. Separations can be performed in the presence of 
essential ions or cofactors, detergents, urea, guanidinium hydrochloride, at high 
or low ionic strength, at 37 °C or in the cold room according to the requirements 
of the experiment. Gel filtration separates molecules according to differences in 
Stokes radius as they pass through the gel filtration medium. Large molecules 
elute from the column first, followed by smaller molecules. 
3.4.1.4 Adenovirus knob purification – size exclusion chromatography 
The cleaved protein was spun down, filtered through a 0.45 µm nitrocellulose 
membrane (Millipore), and concentrated to 50% and diluted in gel filtration 
buffer to reduce the imidazole content. Finally, the protein was concentrated to 
an approximate concentration of 2 mg/ml using a 10 ml Amicon Ultra 
concentrator with a 10 kDa molecular weight (Mw) cutoff (Millipore) at 4 °C. The 
protein was then loaded onto a Hi-load 16/60 Superdex 200 (GE Healthcare) at a 
flow rate of 1 ml/min at 4 °C using gel filtration buffer. 1.5 ml fractions were 
collected, and fractions in the peak corresponding to 70 kDa were pooled. 
3.4.1.5 Adenovirus knob purification –second His-Trap chromatography 
To obtain a homogenous protein sample, uncleaved and cleaved proteins were 
separated with a second His-Trap affinity chromatography run. The column was 
equilibrated in gel filtration buffer, and the sample was loaded onto the column, 
all using an ÄKTATM (GE Healthcare) system at a flow rate of 1 ml/min at 4 °C. The 
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recombinantly expressed Ad knob protein bound unspecifically to the Ni-NTA 
matrix, and was eluted using the lysis buffer containing 50 mM imidazole. The 
protein eluted in approximally 4 ml at a concentration ranging from 1 mg/ml to 6 
mg/ml. A small sample of protein was freeze-tested before storing it at 4 °C. If the 
protein precipitated in the freeze-test, it was stored at 4 °C. Otherwise, it was 
stored at -80 °C. In both cases, the concentration was adjusted with gel filtration 
buffer to 2 mg/ml prior to storage. 
3.4.1.6 Thrombin cleavage 
Cleavage of the N-terminal His tag was performed in the elution buffer 
containing approximately 250 mM imidazole, in a total volume of 30-50 ml. For 
cleavage, 10 U of Thrombin were used for each milligram of recombinant 
protein.  
3.4.2 CD46 purification 
The following purification procedure explains the purification of CD46 SCR1-SCR2 
but the very same protocol was also used for the CD46 SCR1-SCR4 purification. 
The protocol was adapted from the work performed by Jose Casasnovas 
(Casasnovas et al., 1999) and Mykol Larvie (Larvie, 2001). Detailed information 
about buffers used here can be found in the Materials section 2.7 of this thesis.  
3.4.2.1 General - Concanavalin A Sepharose chromatography 
Con A Sepharose™ is Concanavalin A coupled to Sepharose 4B with the 
cyanogen bromide method. Concanavalin A is a tetrameric metalloprotein 
isolated from Canavalia ensiformis that binds molecules containing α-D-
mannopyranosyl or α-D-glucopyranosyl residues and similar structures. Sugar 
binding requires the presence of C-3, C-4 and C-5 hydroxyl groups, as present in 
the high mannose glycans in CD46. 
3.4.2.2 CD46 purification - Con A Sepharose chromatography 
CD46 SCR1-SCR2 was purified by first applying 1000 ml cell culture supernatant to 
the Con A Sepharose resin (GE Healthcare) at a flow rate of 1 ml/min at 4 °C. 
Unspecifically bound protein was removed by washing with 50 ml of Con A 
equilibration buffer. Bound protein was eluted using 100 ml of Con A Sepharose 
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elution buffer. Eluted protein was concentrated to 2 ml using a Centricon Plus -70 
at 4 °C at 3500 g. The Con A elution buffer was exchanged to gel filtration buffer 
by concentrating the pooled fractions to 5 ml, followed by dilution to 25 ml in gel 
filtration buffer, repeated three times. The column was then washed using 50 ml 
of equilibration buffer followed by 50 ml of Con A Sepharose regeneration high 
pH buffer followed by 50 ml Con A Sepharose regeneration low pH buffer. The 
column was then stored in Con A Sepharose regeneration storage buffer, all 
according to the manufacturer’s recommendations.  
3.4.2.3 CD46 purification – size exclusion chromatography 
Concentrated CD46 was applied to a Hi-load 16/60 Superdex 200 (GE 
Healthcare) using a 2.5 ml loop at a flow rate of 1 ml/min using the gel filtration 
buffer, collecting 1.5 ml fractions at 4 °C. Fractions containing the second peak, 
corresponding to CD46, were concentrated to 2 ml at 4 °C, and diluted in 7 ml in 
ion exchange buffer A in order to reduce the NaCl in the gel filtration buffer, thus 
enhancing binding to the ion exchange column. 
3.4.2.4 General - ion exchange chromatography (IEC) 
IEC separates molecules on the basis of differences in their net surface charge. 
The charged groups within a molecule that contribute to the surface charge 
possess different pKa values depending on their structure, and chemical 
microenvironment. Since all molecules with ionizable groups can be titrated, their 
net surface charge is highly pH dependent. IEC chromatography takes 
advantage of the fact that the relationship between net surface charge and pH 
is unique for a specific protein. A protein that has no net charge at a pH 
equivalent to its isoelectric point (pI) will not interact with a charged medium. An 
IEC medium contains a matrix of particles with ionic groups that can be negative 
(cation exchange) or positive (anion exchange). When the entire sample has 
been loaded, conditions are altered in order to elute the bound proteins. 
Proteins are normally eluted by increasing the salt concentration of the buffer or, 
occasionally, by changing the pH. As ionic strength increases the bound proteins 
begin to elute. 
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3.4.2.5 CD46 purification – ion exchange chromatography (IEC) 
The 5/50 MonoQ (GE Healthcare) column was equilibrated in three 10 ml steps; 
first 10 ml ion exchange buffer A, followed by 10 ml ion exchange buffer B and 
finally a second 10ml step with ion exchange buffer A, all at 4 °C. The protein was 
loaded onto the column at a flow rate of 0.8 ml/min. After washing with 20 ml of 
ion exchange buffer A (four column volumes) the protein was eluted in a linear 
gradient extending from 100% ion exchange buffer A to 100% ion exchange 
buffer B over 60 ml, collecting 0.5 ml fractions.  CD46 elutes in three peaks, very 
close to each other, at 10-15% ion exchange buffer B. The three peaks contain 
different glycosylation forms of CD46 (see Results section 4.1.2.4). The first peak 
contains just one glycosylation form and the second and third peak contain a 
mixture of at least two forms. For CD46 SCR1-SCR2 only the first peak, consisting 
of a single glycoform, was pooled and stored at a concentration of 0.5-1.5 
mg/ml at -80 °C. For CD46 SCR1-SCR4 no total separation of the glycoforms was 
possible (see Results section 4.1.2.3), so the purified protein is not entirely 
homogeneous. Here also only the first peak was collected. The CD46 proteins 
from the remaining peaks, which had a lower purity, were saved to be added in 
future purifications.   
3.4.3 Formation of Adenovirus:CD46 SCR1-SCR2 
complex 
CD46 SCR1-SCR2 was incubated at a 1.2 fold molar excess, assuming a 1:1 
binding (one Ad protomer binding one CD46 molecule), with Ad knob protein 
(e.g. Ad11, Ad35, and Ad21) in gel filtration buffer at 4 ºC over night. The protein 
complex was then concentrated to 500 µl using a 4 ml Amicon Ultra 
concentrator (Millipore), filtered, and loaded on to a Superdex 200 10/30 column 
(GE Healthcare) using a 500 µl loop, at a flow rate of 0.5 ml/min at 4 °C. This 
procedure separated saturated Ad:CD46 SCR1-SCR2 complex from excess CD46 
SCR1-SCR2. The uncomplexed CD46 SCR1-SCR2 was collected and saved for 
later preparations.  
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3.4.4 Deglycosylation of CD46 
CD46 SCR1-SCR4 was declycosylated using EndoH (New England Biolabs) at  
20 °C, rotating, over night in the supplied buffer. 20 U of EndoH were used for 
each µg of CD46. The proteins were then separated using gel filtration after 
setting up complex. 
3.4.5 Determination of protein concentration 
The protein concentration was measured using 5 µl of protein in 1 ml of BioRad 
protein Assay (Bradford, Bio-Rad) diluted 1:5. Concentrations were determined 
after measuring the absorbance at a wavelength of 595 nm. Before 
crystallization the protein concentrations was measured using A260 at a 1:100 
and 1:50 dilution in gel filtration buffer to minimize pipetting errors. The 
concentrations were calculated using Eq. 1.  
3.5 Affinity measurements 
3.5.1 Isothermal Titration Calorimetry (ITC) 
3.5.1.1 General - ITC 
Isothermal Titration Calorimetry (ITC) is a thermodynamic technique for 
monitoring interactions between two molecules, A and B. In ITC, a syringe 
containing protein B is titrated into a cell containing a solution of protein A. When 
protein B is injected into the cell, the two proteins interact, and heat is released 
or absorbed in direct proportion to the amount of binding. As protein A becomes 
saturated with protein B, the heat signal diminishes, until only background heat of 
dilution is observed (buffer effect). The measurement of heat generated or 
absorbed allows a fairly accurate determination of binding constants (KD), 
reaction stoichiometry (n), enthalpy ( H) and entropy ( S), thereby providing a 
complete thermodynamic profile of the molecular interaction (Pierce et al., 
1999). 
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3.5.1.2 Experimental setup - ITC 
For the ITC measurements, we used a MicroCal™ VP_ITC Microcalorimeter, with 
a reaction cell of a total volume of 1.4295 ml (ITC equipment located at Max 
Planck Institute for Developmental Biology, Tübingen). The reference cell was 
filled with filtered MQ-H2O supplemented with 0.02% NaN3. During the 
experiments, a reference power of 10 µcal/sec was used on both cells, at a 
temperature of 26 ºC. The measurements were performed in gel filtration buffer 
(see Materials section 2.7) using a concentration of 2 µM protein (setup 1: 
Adenovirus knob, setup 2: CD46 SCR1-SCR2) in the reaction cell. Each dataset 
comprised over 30 equivalent injections, each 300 sec apart. At each data 
point, 4 µl of 25 µM protein solution were injected, over a total time of 8 sec. As a 
negative control the knob affinity for JAM-A (Junctional Adhesion Molecule A), 
which does not bind Ad knobs, was measured. All buffers and proteins were 
filtered through a 0.45 µM (Millipore) filter prior to each experiment. The 
experiments were set up assuming a 1:1 binding model and an nM affinity 
(assuming an affinity that is comparable to the Ad knob binding to CAR, 15 nM) 
(Kirby et al., 1999, 2000). To verify obtained affinities, the experiments were 
repeated twice and, for Ad11 and Ad7, repeated with the knob injected into 
CD46 with CD46/JAM-A in the reaction cell. Data were collected for Ad7, Ad11, 
and Ad11 mutant knobs (R279Q, R279S, R280G, I282L, N283S and D284S). The 
recorded data were analyzed using the Origin 7.0 software with the MicroCal™ 
ITC add-on.  
3.5.2 Surface Plasmon Resonance (SPR) 
3.5.2.1 General - SPR 
The SPR technology is based on detecting a change of mass in an aqueous layer 
close to the sensor chip by monitoring the angular change of reflected polarized 
light (called refractive index). The centerpiece of the technology is a gold 
coated glass surface on which the interactions between two proteins are 
analyzed. The sensorchip contains the gold-coated surface and a matrix 
providing a stable hydrophobic surface onto which molecules can be coupled 
using, for example, amine coupling. In the flow cells, the protein A (analyte) flows 
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over an immobilized protein B (ligand). Binding alters the refractive index, which 
results in an angular change of reflected light on the surface, allowing 
calculations of kinetics and affinity (Torreri et al., 2005).  
3.5.2.2 Experimental setup - SPR 
All interaction assays between different trimeric Ad knob proteins and CD46 
regions spanning domains SCR1-SCR2 and SCR1-SCR4 were performed at 25 °C 
using a BiaCore 2000 system. Knobs interacting with a relatively lower affinity (< 
µM affinity for CD46) had to be coupled by amine coupling to a CM5 chip since 
CD46 binds unspecifically to the Ni-NTA chip at µM concentrations. HBS-EP was 
used as running buffer (see Materials section 2.5.1) in CM5 based assays while in 
NTA based assays HBS-P containing 50 µM EDTA (Sigma) was used. All proteins 
were filtered through 0.2 µM filters (Millipore) before use. Kinetic analysis using a 
50 µl/min flow rate was performed using Ad11-His as non-covalently immobilized 
ligand on a nickel coated NTA chip. Datasets were measured separately for 
CD46 SCR1-SCR2 and CD46 SCR1-SCR4 as soluble analytes. Where kinetic 
analysis was not possible due to very fast interaction rates leading to a “square-
wave” profile a steady-state analysis approach was chosen. Steady-state affinity 
analysis at a 10 µl/min flow rate was performed by covalently immobilizing either 
knob on a CM5 chip via amine-coupling chemistry (Jason-Moller et al., 2006) 
and using either CD46 SCR1-SCR2 or CD46 SCR1-SCR4 as soluble analytes. In the 
performed assays, no surface regeneration was necessary since all interactions 
showed very rapid to moderate dissociation rates. However, the NTA chip was 
stripped of nickel/ligand complex after each interaction cycle using HBS-P 
stripping buffer (see Materials section 2.5.1), followed by new nickel coating of 
the NTA chip and ligand immobilization at the beginning of a new cycle. This was 
done to ensure a constant ligand level in each cycle of a single assay. Raw data 
were processed and analyzed with BIAevaluation software 4.1. Kinetic data was 
fitted using a ‘1:1 binding with mass transfer’ model and steady-state affinity 
data with a model optimized for steady-state affinity (Jason-Moller et al., 2006; 
Torreri et al., 2005).  
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3.6 Functional studies of binding and 
infectivity 
Functional studies were performed by Dr. Marko Marttila, in collaboration with 
the group of Dr. Niklas Arnberg at the Department of Virology at Umeå University. 
The obtained data were analyzed jointly. 
3.6.1 Propagation of 35S-labeled Adenoviruses 
Adenoviruses can easily be amplified in cell culture infecting several types of 
cells (Defer et al., 1990). By amplifying virions under controlled conditions 
radioactive amino acids can be incorporated into the viral proteins. Addition of 
35S-methionine during the translation of viral proteins will result in slightly 
radioactive viral capsids. Radioactively labeled virions allow quantifying binding 
through radioactivity. 35S-labeled virions (Ad11 and Ad7) were produced as 
previously described (Johansson et al., 2007). The identity of the virons was 
determined by digesting viral DNA with restriction enzymes and compared to 
established patterns for prototype strains (Adrian et al., 1986). Aliquoted virions 
were then stored at  80 °C.  
3.6.2 Binding experiments 
Binding experiments to test whether CD46 SCR1-SCR2 is sufficient for Ad11 
binding were performed as follows. 35S-labeled Ad11 virions were incubated with 
increasing concentrations of soluble CD46 SCR1-SCR2 or SCR1-SCR4. After 
incubation with constant agitation, the mixtures were added to A549 cells in a 96 
well plate, washed, and the cell-associated radioactivity was measured 
(Segerman et al., 2003b).  
 For testing whether soluble Ad11, Ad7 or Ad14 knobs can block binding of 
35S-labeled Ad11 or Ad7 particles, the same experimental setup was used, with 
one exception; the soluble knobs were incubated with the cells.   
3.6.3 Fluorescent Focus Assay (FFA) 
In order to investigate whether the observed binding of Ad11 to A549 cells also 
resulted in a productive infection after blocking with soluble CD46, an FFA assay 
Methods 
 43 
was performed in collaboration (Marttila et al., 2005). Briefly, Ad11 virions were 
pre-incubated with increasing concentrations of soluble CD46 SCR1-SCR2 or 
SCR1-SCR4 fragments. After one hour of incubation, the mixtures were transferred 
to 24 well plates containing semi-confluent A549 cells; after one hour non-bound 
virus was removed by washing (3x in PBS). The cells were then incubated for 44 
hours at 37 °C, fixed, and stained with anti-Ad11 rabbit serum. Incubation with a 
FITC-labeled swine anti IgG rabbit serum (Dakopatts, Glostrup, Denmark) allowed 
detection of newly synthesized viral proteins (Segerman et al., 2003a).  
3.7 X-ray crystallography 
3.7.1 Crystallization of proteins 
For crystallization of recombinantly expressed proteins, both the hanging drop 
and the sitting drop method were used (Figure 11). For sitting drop crystallization, 
a Tecan liquid handling system was employed. The advantage of such a system 
is the low consumption of protein (300 nl protein+300 nl buffer solution / drop) in 
comparison with the hanging drop setup, which uses 2 µl to 10 µl drops in a 1:1 
ratio of protein:buffer. A further advantage is the ability to reproduce 
crystallization conditions with high accuracy. Using both setups, the vapor 
diffusion continues until equilibrium has been reached in 2-4 days for salt solutions 
and in up to 25 days for PEG solutions. However, crystals are often obtained long 
after the theoretical equilibrium is reached (Bergfors, 1999). For very volatile 
crystallization precipitants, the hanging drop method is preferred due to the 
lower surface tension of the reservoir: protein mixture. Through vapor diffusion, 
the protein reaches supersaturation where specific aggregates are formed, 
which later form crystals (Figure 12A) (Messerschmidt, 2007). As the protein 
crystallizes, the concentration of free protein in solution decreases and the 
solution enters the metastable region, in which crystal growth is favored (Figure 
12B).  The rate of vapor diffusion can be controlled by changing the temperature 
or by addition of a thin oil layer onto the reservoir solution. For initial crystallization 
conditions Crystal Screens 1 and 2 (Hamton Research) and Wizard Screens 1 and 
2 (Emerald Biosciences) were used (Cudney et al., 1994; Jancarik and Kim, 1991). 
These screens are sparse matrix screens designed to sample a large number of 
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conditions. They are biased towards previously successful crystallization 
conditions for macromolecules published in the Protein Data Bank (PDB). The 
plastic material used for crystallization was obtained from Hampton Research (24 
well plates) and Art Robbins Instruments (96 well plates). 
 
Figure 11. Schematic drawing of A) hanging drop and B) sitting drop crystallization 
setups. In both cases, the protein solution is mixed with reservoir solution containing 
precipitant and buffer. Water will diffuse from the protein drop by vapor diffusion to 
equilibrate with the reservoir solution, which contains a higher concentration of 
precipitant. 
 
 
 
Figure 12. Energy and phase 
diagram for crystallization. (A) 
Energy diagram for crystallization. As 
vapor diffusion occurs, the increase 
in protein concentration forces the 
protein to form nonspecific 
aggregates that, if organized into 
specific aggregates, overcome the 
energy barrier and start to form 
crystals. (B) Phase diagram showing 
phases for crystal nucleation, 
growth and precipitation. As the 
protein and precipitant conc-
entration increases and the energy 
barrier is passed, the protein 
reaches the nucleation point, where 
the protein is ordered in small 
crystals. At this point, the protein 
concentration in solution decreases 
and the drop enters the metastable 
phase, where crystal growth occurs. 
This continues until the setup is fully 
equilibrated (McCoy, 2005). 
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3.7.2 Crystals - the composition of the unit cell 
A crystal is defined by the presence of repeating units of the “unit cell” in three 
dimensions. The crystal lattice falls into one of 14 Bravais lattices (McPherson, 
2003). Crystals can belong to 230 space groups, which are mathematical 
descriptions of the symmetry of the crystal packing (McPherson, 2003). However 
many spacegroups can be eliminated since they do not appear for protein 
crystals due to symmetries such as mirror planes that are absent in proteins. The 
smallest possible element of the unit cell, based on mathematical symmetry 
operators, is called the asymmetric unit (ASU). 
3.7.3 Crystal freezing 
Crystals are usually frozen prior to data collection in liquid nitrogen, at -180 ºC, or 
by moving them into the nitrogen cold stream at the x-ray system. This minimizes 
radiation damage but requires addition of a cryogenic solution to avoid ice 
formation, which can severely damage the protein crystal. In order to prevent 
ice formation one usually adds a cryogenic liquid (glycerol, glucose, 2-methyl-
2,4-pentanediol, PEG) in sufficient concentrations to the reservoir solution. The 
crystals are then transferred in three steps, slowly increasing the concentration of 
the cryoprotectant. In each step the concentration increases with 5-10% (w/v), 
depending on the starting content of cryogenic solution. For the crystal transfer a 
depression well (Hampton Research) is used. Finally the crystal is fished up using a 
fine fiber loop connected to a magnetic base (Hampton research) (Figure 13) 
(Messerschmidt, 2007) (Carter, 1997). When a crystal is exposed to X-rays, the 
majority of photons hitting the protein are absorbed by the crystal. A very low 
percentage of these generate the diffraction pattern, whereas the rest interacts 
with the solvent, generating the background noise, or losing energy in scattering 
events that form radicals (Garman and Owen, 2006). These radicals interact with 
the protein, breaking bonds, thus creating “radiation damage” in the protein 
(O'Neill et al., 2002). The first bonds to be broken are disulfide bridges followed by 
carbon-nitrogen bonds. The radiation damage caused in crystals is directly 
proportional to the energy of the incoming x-ray beam (Sliz et al., 2003). 
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Figure 13. Schematic drawing of a loop used for crystal 
measurements. The crystals were fished into the fiber loop 
after incubation in a reservoir solution supplemented with 
cryoprotectants. The crystals were frozen in liquid nitrogen 
and measured at 
 -180 ºC. 
 
 
 
 
 
 
 
3.7.4 X-rays 
X-rays, or Röntgen rays, are a form of electromagnetic radiation with 
wavelengths ranging from 0.1 to 100 Å. They were discovered in 1895 by Wilhelm 
Conrad Röntgen and named after him (Stanton, 1895). X-rays used in X-ray 
crystallography are usually generated with a rotating copper anode or with 
synchrotron radiation sources. The rotating copper anode generates X-rays by 
focusing electrons onto a copper cylinder in a vacuum, resulting in Kα transitions 
of excited electrons in copper atoms. The Kα transition has a wavelength of 
1.54178 Å (Blow, 2002). The focusing of electrons onto the anode generates heat, 
and the anode has to be rotated and cooled to distribute the heat over a larger 
surface. The second form of X-ray radiation is generated when charged particles 
are accelerated and injected into a curved storage ring. When particles, 
electrons or positrons, travels at high speed in such rings, they emit radiation in 
form of X-rays. The emitted X-rays cover a wavelength range of 0.1-4 Å, but 
radiation with a 1 Å wavelength is usually used.  
3.7.5 Diffraction of X-rays at a lattice 
The layers of a crystal act like reflecting mirrors for the X-rays. Only if the path 
difference of the reflected X-rays is a multiple of 2π does constructive 
interference occur. This is described by Bragg's Law (Eq. 2). If two reflected 
beams with a wavelength of λ travel the same distance from a common lattice 
point, they are exactly in phase. This appears if the lattice plane (A) acts as a 
mirror, or if the distance between the two planes are equal to the wavelength, 
but as that is normally not the case a portion of the X-rays will be reflected at this 
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point. Some will travel to the next lattice plane (B), at the distance d (Figure 14). 
After diffraction at plane B the reflected X-rays will travel a larger distance for 
reaching the target, the detector, in a different phase (the extra path equals 2d 
sin θ). The diffracted X-rays from point A and B will thus cancel each other out, 
partially or completely, or add up to each other (interference), depending on 
the distance. As the same reflection pattern occurs in each unit cell the signal is 
amplified in the crystal.  
 
 
Figure 14. Bragg´s Law. X-rays scattered at a pair of parallel planes. The extra path for X-
rays scattered at the second plane is 2d sin θ. 
 
        Equation 2 
 
Where: 
d= the spacing between two planes 
θ= angle between incoming beam and plane 
λ= wavelength of incoming beam 
n=any integer number  
3.7.6 Data collection 
X-ray data were usually first collected at our home source system, a Rigaku 
MicroMax™-007 HF microfocus X-ray generator (Rigaku) equipped with a 
MAR345 detector (MAR research). As a second step, measurements at the Swiss 
Light Source (SLS, Villigen, Switzerland, Beamline X06SA) or at the European 
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Synchrotron Radiation Facility (ESRF, Grenoble, France, Beamline ID23-1) were 
performed. At the synchrotron facilities, Charge Coupled Device (CCD) 
detectors (MARccd-225 detector at SLS, ADSC Q315 detector at ESRF) and 
recently the Pilatus pixel based detector (Pilatus 6M at SLS) (Bech et al., 2008; 
Schleputz et al., 2005) were used for data collection. Final data sets were always 
collected at a wavelength of 1 Å at 100 K using synchrotron radiation facilities. A 
complete summary of data collection statistics and refinement statistics can be 
found in Appendix 7.3.  
3.7.7 Data processing 
3.7.7.1 Indexing and integration 
For data indexing and integration two programs were used. Initially the HKL 
software package (Otwinowski, 1997) was used for processing data collected at 
our home source, SLS, or at the ESRF. Due to incompatibility problems between 
HKL and the Pilatus pixel detector, the XDS package (Kabsch, 1993) was used to 
process these data. During the indexing procedure, the dimensions of the unit 
cell are determined. During integration, all spots are given an intensity value and 
an h, k, l value (i.e. reciprocal space “coordinates”). DENZO, the integration 
software in the HKL package, allows the user to follow the integration visually 
over the entire data range. This routine subtracts background from a box around 
the integrated spot. The user has the ability to determine the spot shape, but the 
same shape is used over the entire defined group. After refining all parameters 
for one frame, the entire dataset can be run automatically in batch mode, 
writing out files that contain an hkl value and intensity for each reflection for 
each image. 
The program XDS works similarly, with two minor exceptions; XDS writes out 
one file, INTEGRATE.HKL, containing all reflections over the entire data range, 
and the background is determined from the overall background over a range of 
images (defined as coherent pixels higher then the background). XDS also reads 
refined settings saved in files from previous subroutines, allowing the user to rerun 
just the integration step, which can be an advantage since it saves computer 
time.  
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3.7.7.2 Scaling  
The primary functions of scaling are to 1) scale together data recorded on 
several images (called partials), 2) scale up each image to the same level, and 
3) to reduce the data, merging symmetry related reflections. The difference in 
symmetry related equal reflections are used for calculating Rsym (sometimes 
called Rmerge), which is a measure of data quality (Eq. 3). In the set of reflections 
let N stand for at least two symmetry partners that have been measured. Rsym is 
the mean deviation of intensity of these N reflections: 
 
 
      
  and:                                         Equation 3 
  
 
 
  
Where: 
Î= mean intensity of all the measurements 
h= reflection 
i= the symmetry related reflection to h 
I= Intensity 
nh= multiplicity 
 
 
The Rsym can be considered as the mean error of a measured intensity, 
compared to the mean intensity, averaged over a chosen group of reflections 
(Blow, 2002).  
 An Rsym can only be calculated if, (i) a given reflection has been collected 
at least twice, or (ii) if two symmetry related reflections have been collected. As 
more reflections are collected several times, the redundancy of the dataset 
increases, and the Rsym becomes more reliable. Rsym is somewhat flawed because 
it depends on the redundancy of the data. Rsym is written our by both the XDS 
and HKL package. 
 The introduction of Rmeas has solved the problem of redundancy 
dependence; however the problem that more redundant reflections affect the 
overall Rmeas is not considered (Eq. 4). The multiplicity of the reflections might be 
distributed differently in various datasets. Therefore the Rmeas-I was introduced. 
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The Rmeas-I is equal for high and low redundancy datasets at different resolutions 
(Eq. 5)  (Diederichs and Karplus, 1997). 
 
 
 
  and:  Equation 4 
 
 
  
 
                                   Equation 5 
 
 
 
 
Where: and:  
 
 
 
Where: 
P= dataset one 
Q= dataset two 
Ih,p= partially averaged estimates of true intensity for reflection h in dataset P 
Ih,Q= partially averaged estimates of true intensity for reflection h in dataset Q 
 
The R-factors, independent of which of the three calculations are used, 
should increase with higher resolution as the recorded reflections are less intense 
and thus have higher measured errors. An R-factor higher then 0.6 is essentially 
random. Rmeas and Rmeas-I are only calculated in scaling using XDS. 
3.7.7.3 I/σ  
As the intensities (I) of the integrated reflections are listed for each resolution bin, 
a calculated statistical error for each intensity and each bin is also given. From 
this, the I/  is calculated, displaying how much the integrated reflections at a 
certain resolution stand out above background. An I/  of less than one indicates 
an error higher than the measured intensity; thus, no information can be 
extracted concerning the structure of the protein. These data normally also have 
high values of Rsym. To use such data would merely introduce error into the final 
3D-model, therefore a reasonable I/  cutoff between 1.5 and 2.0 is applied to 
the data.  
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3.7.7.4 Wilson plot  
A Wilson plot is a plot of reflection intensities against the resolution (Wilson, 1949). 
For data collected from protein crystals, a characteristic maximum can be 
observed at 6 Å generated from the many 6 Å spacings between atoms in α-
helices or β-sheets. From this point, a linear decrease can be seen beyond 3 Å. 
From this linear part of the Wilson plot, the overall temperature factor (B-factor) 
of the crystallized protein can be estimated as the negative slope of the linear 
gradient. This has implications for later refinement strategies as the B-factors 
determined during refinement should match the value from the Wilson plot.  
3.7.8 Structure determination and truncation of data 
When exposing a protein crystal to X-rays of a given wavelength, amplitude and 
phase, the photons on the path to the detector are absorbed and diffracted by 
hitting electrons in the protein crystal. To reconstitute the structure of the protein, 
a Fourier transformation (Blow, 2002) of the collected data is performed. 
Unfortunately, the phase information is lost during the experiment since the 
detector can only measure the amount of photons hitting it, i.e. intensities.  
Initially the intensities (I) are converted to structure factors amplitudes (F) (French 
and Wilson, 1978) using XSCALE (Kabsch, 1993) or TRUNCATE (CCP4, 1994). The 
structure factor equation represents the sampling of the reciprocal space lattice 
at points, hkl (Eq. 6): 
 
                 Equation 6    
 
Where: 
 = structure factor 
hkl= indices of a reflection 
fj = diffraction contribution from atom j in position xyz. 
N= all atoms in the lattice 
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This can be rewritten as (Eq. 7): 
 
     Equation 7 
 
Where: 
structure factor 
|F(hkl)|=  structure factor amplitude 
 eiα(hkl)= the phase component of the structure factor 
 
The intensity, I, of the collected reflection (hkl) is given by (Eq. 8): 
                            Equation 8 
Where: 
I(hkl)= measured intensity 
k= constant 
F(hkl)= structure factor amplitude 
3.7.9 The phase problem 
In order to calculate an electron density map for model building, the phase of 
each reflection has to be determined. This section explains the method used in 
this thesis, molecular replacement. We first have to introduce how the phase can 
be excluded from the structure factor equations (Eq. 6) by mathematical 
conversions (Patterson, 1934).  
3.7.9.1 Patterson methods 
The intensity of the diffracted X-ray beam is proportional to the square of the 
amplitude of the corresponding wave (see Eq. 8). The Patterson function is 
essentially a Fourier transformation of the intensities rather then the structure 
factors. Thus it can be calculated using structure factor amplitudes alone, which 
is phase independent (Eq. 9). This function can be used to perform molecular 
replacement. 
 
 
Equation 9 
 
 
Where: 
VEZ= Volume of the unit cell 
F(hkl)=structure factor amplitude of reflection hkl 
u,v,w = position vectors in the unit cell 
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3.7.10 General - molecular replacement 
In Molecular replacement, one uses a homology model for phasing the 
collected data. Central to molecular replacement is the Patterson map, which is 
a map of cross vectors between all atoms in the molecule. The Patterson map is 
calculated without any phase information according to equation 9. The 
Patterson map for molecule A is rotated and translated onto the Patterson map 
for molecule B (Figure 15). The search is performed within a user defined sphere. 
After the search, the solutions with the highest correlation are listed. Good 
solution should have high correlation coefficients and low R factors (between 
collected and calculated data, i.e. search model) (see Eq. 10 and 11). Each 
tested position can be defined by the three angles of rotation and the three 
translation vectors. The search model is reoriented in space to the position giving 
the highest correlation and lowest R-factors. The model, in its new orientation, is 
used for calculating phases that can be used for refinement. These calculations 
are easier in reciprocal space than real space.  
 
            
 
Figure 15. A simple known molecule (A) and an unknown, homologous molecule (B) and 
their corresponding Patterson maps. 
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         Equation 10 
 
 
 
With:  
 
Where: 
Fobs= observed structure factor amplitude (Eq. 6) 
Fcalc= calculated structure factor amplitude for the model (Eq. 6) 
|F|= structure factor amplitude search model (Eq. 6) 
<F>= structure factor amplitude collected data (Eq. 6) 
   
                             
 
 
                                     Equation 11 
 
 
 
Where: 
Fobs= measured structure factor amplitude 
Fcalc=calculated structure factor amplitude 
h= reflection 
 
3.7.10.1 Molecular replacement – rotation/translation functions 
In this work, exclusively AMoRe (Navaza, 1994) and Phaser (Read, 2001) were 
used for molecular replacement. Phaser was always used in a completely 
automated way, and AMoRe was used when the rotation (ROTING subroutine) 
and translation (TRAING subroutine) functions had to be run independently to 
pick up the correct solution. Both programs compute the structure factor directly 
from the initial model after applying the rotation matrix and the translation 
vector, which moves the search model to the new position.  
AMoRe includes routines to run a complete molecular replacement 
search by carrying out rotation and translation functions against various targets. 
Euler angles define the rotation part of the solution and fractional shifts, the 
translation part of the solution. The search is followed by an automatic rigid body 
refinement. The AMoRe cross-rotation function calculates a correlation 
coefficient between the observed and calculated Patterson functions. Good 
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solutions should give high correlation coefficients between observed and 
calculated Patterson functions well as low Rfactors.  The software contains routines 
for calculating structure factors from the model in a P1 cell (Navaza, 1994). 
 The maximum likelihood molecular replacement program Phaser 
combines the anisotropy correction, likelihood enhanced fast rotation function, 
likelihood enhanced fast translation function, packing and refinement modes for 
multiple search models and a set of possible spacegroups to automatically solve 
a structure by molecular replacement. The signal-to-noise ratio is judged using 
the Z-score. A score above three is considered a solid solution, which is 
computed by comparing the log likelihood gain (LLG) values from the rotation or 
translation search with LLG values for a set of random rotations or translations. 
The mean and the root mean square (RMS) deviation from the mean are 
computed from the random set, then the Z-score for a search peak is defined as 
its LLG minus the mean, all divided by the RMS deviation (McCoy et al., 2007). 
3.7.11 General - structure refinement 
For structure refinement the CNS (Brunger et al., 1998) and REFMAC5 (CCP4, 
1994) software packages were used. During the refinement, the model is 
converted to structure factor amplitudes (Fcalc) by a reverse Fourier 
transformation. These are compared to the measured intensities (Fobs) according 
to Equation 11. The aim during the entire refinement is to minimize the difference 
between Fobs and Fcalc (Eq. 11) by refining xyz coordinates and B-factors. To avoid 
biasing the model, a random selected “test-set” of reflections is excluded (RFree) , 
containing a minimum of 5% of the total reflections, to be used for cross-
validation. The percentage of reflections used for the test set is set to contain 
enough reflections for a statistical relevance in the resolution bins. As one spot of 
the diffraction image contains information about all the atoms of the model, a 
good model should predict the intensities of the reflections of the test set. This is 
assessed by the use of free R factors, an R factor calculated between Fobs and 
Fcalc using the free set of reflections that is not used in the refinement (Brunger, 
1992). The Rfactor should be carefully monitored during refinement, and an 
improvement of the working model should reduce both R-factors in a similar way. 
Refinement includes several approaches: 
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3.7.11.1 Rigid body refinement 
After molecular replacement, it is sensible to perform a rigid body refinement, 
where the orientation of the entire molecule in relation to the unit cell axis is 
refined. During rotation and translation, several rigid bodies can be defined from 
one single molecule, e.g. two domains can be rotated independently. Even 
though both REFMAC5 (CCP4, 1994) and CNS (Brunger et al., 1998) allow rigid 
body refinement, the rotation and translation performed by CNS is much more 
powerful. Rigid body refinement is normally performed using data between 12 Å 
and 3 Å. The 3 Å resolution cutoff gives a higher radius of convergence given 
that the smallest details observed are 3 Å apart, like for example the strands in a 
β-sheet. This allows a movement of the molecule over larger distances in one 
cycle, e.g. higher radius of convergence.  
3.7.11.2 Restrained refinement 
During restrained refinement, known stereochemical parameters like planarity, 
bond distances and angles, torsion angles etc. are used for improving the 
model. The geometric parameters are weighted against the crystallographic 
terms by the programs with a factor. In CNS is this factor automatically set and in 
REFMAC5 several factors have to be tested, and the user determines which one 
to use based on the refinement statistics written out with each factor. 
3.7.11.3 B factor refinement 
During refinement one should also refine the B-factors. At 3 Å resolution, or worse, 
the slope in the Wilson plot is normally poorly defined and overall B-factors are 
refined giving all amino acids the same B-factors. With better data the B-factors 
can be refined in groups, where for example different domains in the model are 
given the same B-factors. The third type of B-factor refinement is called individual 
B-factor refinement. During this refinement the B-factors can be refined either, (i) 
isotropically, defining the B-factors as a sphere, or (ii) anisotropically.  Anisotropic 
refinement requires a resolution of better then 1.6 Å. The B-factors are then 
defined as an ellipse that allows different movement in each of the 6 dimensions.  
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3.7.11.4 Calculation of electron density maps 
The refinement is normally run over several cycles. Density maps are calculated 
based on the newly refined model (Eq. 12). The map routine calculates maps 
only at grid points, in order to save computer time during the Fourier 
transformation (Blow, 2002). The grid is normally set to 1/3 of the resolution. 
 
 
        Equation 12 
 
Where: 
ρ(xyz)= the density of the unit cell at position (xyz)  
V= the volume of the unit cell 
F(hkl)= structure factor amplitude 
 
3.7.11.5 Density modification- averaging 
For some of the structures presented in this work, density modification was 
exploited due to the presence of non-crystallographic symmetry (NCS), i.e. 
symmetry that applies locally but not throughout the crystal. If the asymmetric 
unit contains n molecules of one type (n>1), one can make the assumption that 
these molecules are close to identical, and average the electron density for 
these molecules in order to improve the electron density map (Figure 16).  For 
using averaging as a powerful tool, one has to be certain that the NCS is really 
present and that the rotation matrices and translation vectors are exact, 
otherwise the averaged density will be unclear.  Prior to averaging, a mask has 
to be created surrounding the molecule to be averaged. If no initial model exists, 
averaging can be defined by a sphere or box around a given coordinate, i.e. a 
heavy atom position. In both cases an accurate transformation matrix from area 
A to area B has to be determined. As the electron density for molecules A and B 
are averaged, noise generated from measuring errors is reduced. The result will 
be a cleaner map, which facilitates the tracing of chains (Blow, 2002). This 
process can be run iteratively. 
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 Figure 16. Schematic drawing of an averaging 
procedure. The red boxes indicate input to be 
supplied for averaging (F, θ= initial amplitude and 
phase; F´, θ´= improved amplitude and phase). The 
cycle can be repeated until convergence is 
reached, e.g. structure factor amplitude and phase 
changes become minimal in each cycle (“dotted 
arrow”).  
 
 
 
 
 
 
Averaging can be performed using the CCP4 package (MAPMASK, MAPAVE, 
LSQKAB) (CCP4, 1994) or the RAVE package (AVE, MAMA, MAPMAN, IMP)  
(Jones, 1992; Kleywegt, 2001). In this work, both packages were used. 
3.7.12 The Matthews coefficient 
The work performed by Matthews (Matthews, 1968) has become a useful 
statistical tool for crystallographers. Matthews statistically studied crystallized 
proteins, more specifically the solvent content in known protein structures. He 
showed that proteins have a Matthews parameter (Vm) ranging from 1.9-4.2 
Å3/da. Protein molecules have a rather constant density of 1.33 g/m3 that 
corresponds to a volume of about 1.3 Å3/ da. The Vm describes the density, or 
volume occupied by protein, within the crystal. Protein crystals do not show a 
constant density because of their solvent content (Eq. 13). 
 
          Equation 13 
 
Where: 
Vol= Unit cell volume (Å3),  
M= Molecular weight of the protein in Daltons 
nasym= number of asymmetric units  
nmol= number of molecules in the asymmetric unit.  
 
 
By solving nmol one is able to obtain an estimation of how many molecules are 
present in the unit cell in the crystal. This is useful information when one wants to 
determine a structure.  
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4 Results 
4.1 Protein purification 
Detailed information about all the buffers used in the protein purification can be 
found in the Materials section 2.7. 
4.1.1 Adenovirus knobs 
The purification for all recombinantly expressed Ad knobs followed the same 
protocol, with the total yields ranging from 1.5 mg/l (Ad11) to 50 mg/l (Ad35). All 
knobs could be purified to high purity. The mutant knobs precipitated upon 
freezing and were consequently stored at 4 ºC and not -80 ºC. 
4.1.1.1 HisTrap affinity chromatography 
The HisTrap chromatography was performed according the Methods section 
3.4.1.2. The first peak, eluting at about 100 mM, contained some recombinant 
protein but mostly impurities and was discarded. The second peak, eluting at 250 
mM imidazole, contained mainly pure protein. This peak was used for further 
purification (Figure 17). 
 
Figure 17. Affinity column chromatography of the Ad11 knob using a HisTrap column. 
(A)The recombinantly expressed protein elutes at a concentration of 250 mM imidazole. 
(B) The corresponding 12% SDS-PAGE with P= pellet, S= soluble fraction, FT= flow through, 
W= wash, E1= elution peak 1 and E2= elution peak 2. Molecular weight markers (kDa) are 
shown on the left (lane “M”). 
 
Results 
 60 
4.1.1.2 Cleavage of N-terminal hexa-histidine (His) tag 
During thrombin cleavage, some protein precipitated if the total amount of 
protein exceeded 20 mg. Addition of 15% glycerol improved the yield 
significantly without affecting the cleavage efficiency (data not shown). The 
cleavage was performed in 50 ml tubes rotating at 20ºC for 16 hrs (Figure 18). 
Cleaved protein was concentrated to about 50% volume, and diluted in gel 
filtration buffer to reduce the concentration of imidazole. Finally, the protein was 
concentrated to 2 mg/ml (measured using Biorad Protein Assay; Bradford) 
before gel filtration.    
 
Figure 18. Thrombin cleavage of the Ad11 knob. Lane A 
uncleaved and and lane B, cleaved knob. Thrombin contains 
some impurities. 
 
 
 
 
 
 
 
 
 
 
4.1.1.3 Size exclusion chromatography 
The gel filtration was performed according to Methods section 3.4.1.4. The Ad 
knobs eluted as trimers, as expected. All knobs form dimers of trimers (Figure 19) 
over time, which can be separated on a Superdex 200. The dimer is not caused 
by disulfide bridges as a non-reducing gel gave the same result (data not 
shown). The dimerization can be avoided by storage at -80 ºC. During gel 
filtration, some aggregation was also observed (Figure 19).  
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Figure 19. Gel filtration chromatography of the Ad11 knob. (A)Some aggregation is 
observed close to the void volume of the column (peaks at fraction 1). The protein elutes 
in a very symmetric peak at the corresponding size. (B) A 12% SDS-PAGE of the peak 
fraction. First, the dimer of trimer appears, due to its larger size. In fraction 35 the normal 
trimer is seen. Molecular weight markers (kDa) are shown on the left (lane “M”). 
 
4.1.1.4 Second HisTrap affinity chromatography 
After gel filtration, the protein sample is pure, but not homogenous since the 
cleavage efficiency is never 100%. To remove remnants of His-tagged protein a 
second HisTrap chromatography has to be used for separating the two protein 
species prior to crystallization trials. The chromatography run was performed 
according to Methods section 3.4.1.5. All the knobs described in this thesis bound 
unspecifically to the column. The interaction is very weak, and untagged protein 
could be eluted using lysis buffer (50 mM imidazole) in one sharp peak at high 
concentration (Figure 20). The uncleaved protein was eluted using HisTrap elution 
buffer and discarded.   
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Figure 20. Second HisTrap chromatography of Ad11 knob. (A) Chromatogram. (B) The 
purified protein was run in increasing amounts, on a denaturing 12% SDS-PAGE. The size 
corresponds to a protomer (C1-C4 = increasing amounts of Ad11 knob, in each step 
double the amount). Molecular weight markers (kDa) are shown on the left (lane “M”). 
 
4.1.2 Purification of CD46 constructs 
CD46 SCR1-SCR2 and CD46 SCR1-SCR4 proteins were expressed in CHO (Chinese 
Hamster Ovary) Lec 3.2.8.1 cells (Stanley, 1989). The purification for the two forms 
of CD46 follows the same protocol and will be presented together. 
4.1.2.1 Concanavalin A Sepharose- affinity chromatography 
The purification was performed using peristaltic pumps, and elution was 
monitored by SDS-PAGE (Figure 21). CD46 SCR1-SCR4 was analyzed using a 12% 
SDS-PAGE, whereas the smaller CD46 SCR1-SCR2 was analyzed by a 15% SDS-
PAGE. 
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Figure 21. SDS-PAGE confirming elution of both forms of CD46 from Con A Sepharose. (A) 
CD46 SCR1-SCR2 was analyzed on a 15% SDS-PAGE and (B) CD46 SCR1-SCR4 on a 12% 
SDS-PAGE. Both proteins elute over a total volume of 100 ml. Molecular weight markers 
(kDa) are shown on the left (lane “M”). 
 
4.1.2.2 Size exclusion chromatography 
CD46 was next applied to a gel filtration column (see Methods section 3.4.2.3). 
The first peak in the elution profile is most likely heavily glycosylated FCS 
components, since the height of the peak varied with the FCS content in the 
loaded cell supernatant (data not shown) (Figure 22 and Figure 23).  A total 
separation of the FCS components and CD46 was never possible, and some 
CD46 had to be sacrificed for purity. The retention times of the two proteins were 
as expected (Figure 22A and Figure 23A). The collected fractions (in total about 
10 ml) were loaded on a SDS-PAGE for analysis (Figure 22B and 23B). CD46 SCR1-
SCR4 runs as two bands, which are likely two forms of glycosylation. 
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Figure 22. Size exclusion chromatography of CD46 SCR1-SCR2. (A) Gel filtration 
chromatogram and (B) the corresponding SDS-PAGE. Molecular weight markers (kDa) 
are shown on the left (lane “M”). 
 
 
Figure 23. Size exclusion chromatography of CD46 SCR1-SC4. (A) Gel filtration 
chromatogram and (B) the corresponding SDS-PAGE. Molecular weight markers (kDa) 
are shown on the left (lane “M”). 
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4.1.2.3 Ion exchange chromatography 
In order to obtain highly homogeneous protein, ion exchange chromatography 
(IEC) was employed (IEC details in Methods section 3.4.2.5). For CD46 SCR1-SCR2, 
a highly pure homogeneous, protein was obtained, whereas for the longer 
construct pure CD46, in at least two different glycosylation forms, was obtained 
(Figures 24 and 25). Initially, no crystallization trials were planned using an Ad 
knob in complex with CD46 SCR1-SCR4, so the protein was considered to be 
homogeneous enough in that form. Both forms bind Ad knobs, independent of 
glycans (data not shown). 
 
 
Figure 24. Analysis of IEC run of CD46 SCR1-SCR2. (A)The IEC chromatography allowed a 
separation of the two glycosylation forms. The first peak (fractions 20-23) contains only 
one glycoform. The second peak (fraction 24-28) contains both glycoforms, and was 
saved for later purifications. (B) 15% SDS-PAGE with the peak fractions. Molecular weight 
markers (kDa) are shown on the left (lane “M”). The mismatch between the fractions in 
the gel and in the chromatogram is due to the deadvolume between the UV-cuvette 
and fraction collector. 
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Figure 25. Analysis of IEC run of CD46 SCR1-SCR4. (A) Chromatogram of an IEC run 
separating several impurities from CD46. (B) 12% SDS-PAGE of CD46 SCR1-SCR4. The 
peaks contain several glycosylation forms. Molecular weight markers (kDa) are shown on 
the left (lane “M”). The mismatch between the fractions in the gel and in the 
chromatogram is due to the deadvolume between the UV-cuvette and fraction 
collector. 
 
4.1.2.4 Deglycosylation of CD46 
Deglycosylation of CD46 SCR1-SCR4, using EndoH (details in Methods section 
3.4.4), results in one band. This confirms that the two bands seen in the gel are 
both CD46, in different states of glycosylation. A large amount of EndoH was 
used (Figure 26).  
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Figure 26. EndoH digestion of CD46 
SCR1-SCR4. The two species of 
CD46 are cut and shifts to the 
same size supporting two 
glycosylation forms of the protein. 
Molecular weight markers (kDa) 
are shown on the left (lane “M”). 
 
 
 
 
 
 
 
 
 
 
 
 
4.1.3 Complex formation 
4.1.3.1 CD46 SCR1-SCR2:Adenovirus knob 
The separation of saturated complex and excess CD46 was performed using gel 
filtration (see Methods section 3.4.3). The complex elutes at a molecular weight 
corresponding to 140 kDa, whereas excess CD46 SCR1-SCR2 eluted at about 20 
kDa. The excess CD46 was saved for later complex formations. The gel shows a 
nice separation between the complex and CD46, as expected (Figure 27) by 
their large size difference. 
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Figure 27. Gel filtration of the Ad11:CD46 SCR1-SCR2 complex. (A) The gel filtration run 
separated saturated complex (left peak) from the excess CD46 (right peak).  (B) the 12% 
SDS-PAGE, from both peaks. Molecular weight markers (kDa) are shown on the left (lane 
“M”). The mismatch between the fractions in the gel and in the chromatogram is due to 
the deadvolume between the UV-cuvette and fraction collector. 
 
4.1.3.2 CD46 SCR1-SCR4:Adenovirus knob 
Isolation of the CD46 SCR1-SCR4 complex was done in a similar way to the CD46 
SCR1-SCR2 complex (see Methods section 3.4.3) (Figure 28). 
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Figure 28. Gel filtration of the Ad11:CD46 SCR1-SCR4 complex. (A) The gel filtration run 
separated saturated complex (left peak) from the excess CD46 (right peak).  (B) 12% SDS-
PAGE showing only fractions from the larger peak. Molecular weight markers (kDa) are 
shown on the left (lane “M”). The mismatch between the fractions in the gel and in the 
chromatogram is due to the deadvolume between the UV-cuvette and fraction 
collector. 
 
4.2 Crystallization and structure 
determination 
4.2.1 The Ad11 knob 
4.2.1.1 Crystallization of the Ad11 knob 
In order to provide a structural basis for the Adenovirus interaction with CD46, we 
first determined the crystal structure of the unliganded Ad11 knob. The purified 
knob was crystallized using the hanging drop method, with 2 µl drops (1:1 ratio 
reservoir:protein), a protein concentration of 8 mg/ml, and a temperature of  
20 ºC. Well diffracting crystals were obtained after initial screening in 12 hrs over 
a reservoir containing 18% (w/v) PEG 6000, 0.1 M Hepes pH 7.0 (Figure 29). The 
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crystals allowed us to determine the structure at 1.45 Å resolution with excellent 
statistics (Table 2, Appendix 7.3). 
 
Figure 29. Crystals of the Ad11 knob grown using the 
hanging drop method. The largest crystals had a size of 
about 150 x 150 x 150 µm. 
 
 
 
 
 
 
 
4.2.1.2 Structure determination of the Ad11 knob 
The crystals were flash frozen in a cryogenic solution supplemented with 20% 
PEG600 to avoid ice formation. X-ray data were collected at the Swiss Light 
Source (SLS, Villigen Switzerland) beamline X06S using a MarCCD detector (Mar 
research). The data were indexed, integrated and scaled using the HKL 
package (Otwinowski, 1997). The protein crystallized in the cubic space group 
I23, with one monomer in the asymmetric unit, placed on the three fold rotation 
axis of the diagonal of the unit cell. Initial phases were obtained by molecular 
replacement in AMoRe (CCP4, 1994) using the Ad3 knob (PDB accession number 
1H7Z, 49.5% homology). The sequences were aligned and amino acids in close 
proximity to gaps/insertions were removed. Remaining amino acids were 
mutated to the Ad11 sequence using COOT (Emsley et al., 2004). Molecular 
replacement search using AMoRe, in a resolution range between 12-3.5 Å using 
a 30 Å sphere, gave one solution that refined well in CNS (Brunger et al., 1998) 
(Table 2). 
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Table 2. Essential crystallographic statistics for the structure determination of the Ad11 
knob. More detailed statistics can be found in Appendix 7.3. 
 
Data quality  
Space group I23 
Unit cell dimensions (Å) a=100.6 
Resolution range (Å) 40-1.45 (1.45-1.50) 
Completeness (%) 99.9 (100.0) 
Redundancy 6.0 (5.4) 
RSym(%)1 4.5 (38.8) 
I/  13.2 (1.56) 
Refinement statistics  
RWork(%)2 18.8 
RFree(%)2 21.6 
Highest-resolution shell is shown in parentheses.  
 
1-Defined in the Methods section 3.7.7 
2-Defined in the Methods section 3.7.10 
Free set contains 5% of reflections (see Methods section 3.7.10) 
 
4.2.1.3 Overall structure of the Ad11 knob 
Each Ad11 knob protomer folds into an eight-stranded anti-parallel  -sandwich, 
and three of these assemble into a propeller-like trimer with an extensive 
interface (see Introduction; Figure 4). Although the Ad11 knob is homologous in 
sequence to knobs from other serotypes, it differs in loop regions that define the 
receptor interactions, especially in the AB-, HI- and IJ-loops. Mutational studies 
have indicated that an epitope responsible for the interaction with CD46 is 
located around Ad11-R279, in the N-terminal part of the HI-loop. By constructing 
chimeras between the Ad7 knob, which was thought not to bind CD46, and the 
Ad11 knob the region responsible for CD46 binding was identified as region 279-
283 (Gustafsson et al., 2006). The N-terminal 10 amino acids are disordered and 
not visible in our structure. 
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4.2.2 Structure of the CD46 SCR1-SCR2:Ad11 knob 
complex 
4.2.2.1 Crystallization of the complex 
To define the interactions of Ad11 with its receptor CD46 at the atomic level, we 
solved the structure of the complex between the N-terminal two SCR domains 
(SCR1-SCR2) of CD46 and the Ad11 knob. Crystallization was performed at room 
temperature using the hanging drop method (2 µl drops in a 1:1 ratio between 
reservoir solution and protein) at a protein concentration of 8 mg/ml. 100 x 60 x 
30 µm crystals were obtained at 20 ºC after initial screening in one week over a 
reservoir containing 35% (w/v) PEG200, 200 mM CaCl2, 100 mM Tris pH 8.0 (Figure 
30). Crystals were harvested, flash frozen in liquid nitrogen, and measured at the 
SLS (Villigen, Switzerland) using a MAR CCD detector (Mar research).  Since the 
crystallization condition contains such a high concentration of PEG200, no 
additional cryoprotectant was needed.  
 
Figure 30. Halfmoon shaped crystals of the 
Ad11: CD46 complex. 
 
 
 
4.2.2.2 Structure determination of the Ad11 complex 
Data were collected from several crystals, and images were integrated and 
reduced using the HKL package (Otwinowski, 1997). The structure was solved by 
molecular replacement as implemented in AMoRe (CCP4, 1994) using the crystal 
structure of the unliganded Ad11 knob and, separately, the SCR1 and SCR2 
domains of CD46 (Casasnovas et al., 1999) (PDB code 1CKL). After placement of 
the two Ad11 knobs, the SCR1 and SCR2 domains of CD46 could be placed 
unambiguously. After several rounds of refinement using CNS (Brunger et al., 
1998) and model adjustments using Coot (Emsley et al., 2004), convergence was 
achieved. The final structure has R-factors of 23.4% (working set) and 28.7% (free 
set), for all data between 40 and 2.85 Å (Table 3).  
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The asymmetric unit of the crystals contains two Ad11 knob chains and 
two CD46 SCR1-SCR2 chains. These chains belong to two different trimers that 
are generated by crystallographic 3-fold symmetry axes located at the origin 
and the center of the P3 unit cell.  Non-crystallographic symmetry restraints were 
used throughout the refinement, excluding loop residues and termini. The N-
terminal ten residues of each monomer in the Ad11 knob are disordered in both 
copies. Therefore these residues are not included in the final model. All structural 
features, and especially all details of the Ad11 knob-CD46 interaction, are 
identical in both copies of the complex.  
 
Table 3. Essential crystallographic statistics of the crystallized complex between Ad11 and 
CD46 SCR-SCR2. More detailed statistics can be found in Appendix 7.3. 
 
Data quality  
Space group P3 
Unit cell dimensions (Å) a=b=106.14 c=68.32 
Resolution range (Å) 40-2.85 (2.85-2.95) 
Completeness (%) 93.2 (83.0) 
Redundancy 4.1 (4.0) 
RSym(%)1 5.9 (32.5) 
I/  7.23 (2.64) 
Refinement statistics  
RWork(%)2 23.4 
RFree(%)2 28.7 
Highest-resolution shell is shown in parentheses.  
 
1-Defined in the Methods section 3.7.7 
2-Defined in the Methods section 3.7.10 
Free set contains 10% of reflections (see Methods section 3.7.10). 
 
4.2.2.3 The overall structure of the Ad11: CD46 SCR1-SCR2 complex 
The Ad11 knob binds three CD46 molecules. Each CD46 unit lies diagonally 
across an interface between two Ad11 knob protomers, making contacts with 
both (Figure 31A). The SCR domains of CD46 form  -barrels with a small 
hydrophobic core and two disulfide bonds, sealing each domain at the top and 
the bottom. The SCR1-SCR2 repeats of CD46 adopt an almost linear, rod-like 
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conformation. The CD46 fragment used here carries two glycans. Although only 
a portion of one glycan (at Asn80 in SCR2) is clearly visible in our electron density 
maps, the position of the second glycan (at Asn49 in SCR1) can be inferred from 
weak electron density. Both glycans face away from the virus-binding surface 
and do not interact with Ad11 knob.  
The Ad11 knob-CD46 interface is extensive with the Ad11 knob covering 
almost the entire length of the glycan-free side of the receptor, from the mid-
section of SCR1 to the base of SCR2, occluding an area of 1670 Å2 (calculated 
using Contact (CCP4, 1994) from solvent. The interface features a strong 
complementarity in shape, with many direct protein-protein contacts and few 
water molecules mediating interactions (Figure 31B). 
 
 
Figure 31. Structure of the Ad11 knob in complex with CD46 SCR1-SCR2. (A) Ribbon 
drawing of the complex. The three subunits forming the Ad11 knob are shown in blue, 
green and grey; bound CD46 SCR1-SCR2 is in red, with Asn49 and Asn80 shown in red 
and the glycans attached to Asn80 shown in yellow. The glycan attached to Asn49 is 
poorly ordered in the crystals and was not modeled. Disulfide bonds are shown in yellow. 
The view is along the three-fold axis. In this view, the Ad11 fiber shaft (and hence the virus 
particle) would be located below the plane of the paper; the cell bearing CD46 would 
be above it. (B) Surface representation of the complex. The two Ad11 knob monomers 
that contact CD46 are shown in blue and green, bound CD46 SCR1-SCR2 is in red, and 
the glycan attached to SCR2 is in yellow. To highlight the striking shape complementarity 
between the interfaces, CD46 has been translated away from the Ad11 knob by about 5 
Å. The color code is the same as that used in panel A. Figures made in PyMOL (DeLano, 
2002). 
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4.2.2.4 The binding interface 
The majority of contact residues are contributed by a single Ad11 knob protomer 
(blue in Figure 31B), which interacts with SCR1 and with the SCR1-SCR2 interface. 
A second Ad11 knob protomer (green in Figure 31B) provides additional contact 
points with the base of SCR2. Although they cover a continuous surface, the 
contacts between the Ad11 knob and CD46 can be divided into three distinct 
regions (Figure 32A). The first region is centered at the HI-loop of Ad11 knob and 
residues at the side of SCR1 (Figure 32B). A large contact that helps to define 
shape complementarity is contributed by Tyr36 of CD46, which interacts tightly 
with the main chain of the Ad11 knob HI-loop. Additional contacts in this area 
include several hydrogen bonds between main chain atoms, as well as a salt 
bridge between Asp284 of Ad11 knob and His43 of CD46. The second region 
involves the HI- and DG-loops of Ad11 knob, which make extensive contacts with 
the SCR1-SCR2 interface (Figure 32C). A key residue here is Arg280 of the Ad11 
knob, which forms a bi-dentate salt bridge with Glu63 of CD46. The hydrophobic 
portion of Arg280 docks against the Phe35 side chain in SCR1. Several additional 
polar and non-polar contacts strengthen the interactions in this region. The third 
contact is formed between the IJ-loop of a neighboring monomer of Ad11 knob 
and the lower portion of SCR2 (Figure 32D). Contacts in this region feature two 
hydrogen bonds, both involving the main chain of CD46. The relative position of 
the Ad11 knob and SCR1-SCR2 molecules in the complex indicates that regions 
missing in the two proteins (the N-terminal shaft of Ad11 fiber and domains SCR3-
SCR4 of CD46) would face in opposite directions.  
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Figure 32. Interaction between Ad11 knob and CD46 SCR1-SCR2. Panel (A) shows a 
ribbon tracing of the complex using the color code from Figure 31. Panels (B) to (D) show 
detailed views of the three major contact regions involving the HI-, DG- and IJ-loops of 
Ad11 knob. The color scheme is based on that used in Figure 31: The two Ad11 knob 
monomers are in blue and green, respectively, and CD46 is shown in orange. Nitrogen 
and oxygen atoms of side chains are shown in blue and red, respectively. Hydrogen 
bonds and salt bridges (distance < 3.5 Å) are represented with dashed grey lines. Key 
residues are labeled using single-letter code. Figure made in Ribbons (Carson, 1997). 
4.2.2.5 Binding and infectivity studies 
To prove the hypothesis that the outer two domains of CD46 are sufficient for 
Ad11 binding, we performed a binding assay using 35S-labeled Ad11 particles 
and a fluorescent focus infectivity assay (FFA). Recombinant soluble CD46 SCR1-
SCR2 and CD46 SCR1-SCR4 fragments were incubated together with virus 
particles for one hour on ice before mixing with human respiratory epithelial cells 
(A549 cells). After washing, the cells were analyzed for the amount of bound 
radioactive particles. For the FFA the cells were grown for 48 hrs at 37ºC before 
fixation and staining. Soluble CD46 SCR1-SCR2 and SCR1-SCR4 blocked binding 
and subsequent infectivity at nearly identical doses and with very similar kinetics 
(Figure 33).  
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Figure 33. Fragments SCR1-SCR2 and SCR1-SCR4 of CD46 are equally efficient in 
preventing Ad11 from binding to and infecting A549 cells. Various concentrations of 
soluble SCR1-SCR2 or SCR1-SCR4 were incubated (A) with 35S-labeled Ad11 and then 
allowed to bind to A549 cells on ice, or (B) with non-labeled Ad11 on ice and then 
allowed to infect A549 cells. Panel (C) shows infection of A549 cells with labeled Ad11, 
either adding no CD46 protein (top), purified SCR1-SCR2 (middle) or purified SCR1-SCR4 
(bottom). 
 
4.2.2.6 Affinity measurements 
Number of contacts and extent of the binding surface indicate very tight 
binding. We decided to measure the Ad11 knob affinity for CD46 SCR1-SCR2 
using isothermal calorimetry measurements (ITC). The reaction is exothermic and 
places the affinity of the Ad11 knob for CD46 SCR1-SCR2 around 2 nM (Figure 34) 
(see Methods section 3.5.1). 
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Figure 34. ITC measurements placed the Ad11 
affinity for CD46 in the range of 2 nM. CD46 
was injected into the reaction chamber 
containing Ad11 knobs. (A) Each of the 30 
injections of CD46 results in a peak. The area 
under each peak corresponds to the heat 
released. (B) Integrated heat values plotted 
against molar ratio of ligand. 
 
 
 
 
 
 
 
 
 
4.2.2.7 The Ad11 knob alters the conformation of its cellular receptor 
CD46 
Perhaps the most striking feature of the Ad11 knob-CD46 complex is that the 
relative orientation of the two SCR domains of CD46, and thus the overall shape 
of the receptor, is dramatically changed from that seen in the unliganded 
structure (Casasnovas et al., 1999) (Figure 35A). We conclude, therefore, that 
Ad11 knob induces a profound conformational change in CD46 by realigning 
the two repeats and molding them into a rod-like segment. The change in 
conformation not only alters the relative orientation between Ad11-binding 
epitopes on SCR1 and SCR2 but also modifies the overall surface structure of 
CD46; exposing residues for binding that were hidden in the unliganded structure 
(Figure 35B; Figure 36).  
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Figure 35. Ad11 knob induces a large conformational change in CD46. Shown here is a 
superimposition of the SCR2 domains of unliganded (Casasnovas et al., 1999) (blue) and 
liganded CD46 (red). The two Ad11 knob monomers that interact with CD46 are shown 
as grey ribbon tracings. (A) Overall structure. The arrow indicates the rearrangement of 
SCR1 upon binding to Ad11 knob. Asparagine side chains at positions 49 and 80 carry 
glycans. The glycan attached to Asn49 in the liganded structure is poorly ordered; 
glycans of the unliganded structure are not shown for reasons of clarity. (B) Close-up 
view of the interaction, using the same superposition and color code. Key amino acids of 
CD46 that take part in complex formation are shown in orange (CD46 bound to Ad11 
knob) and light blue (unliganded CD46). Residues are labeled in single-letter code. 
Figure made in Ribbons (Carson, 1997). 
 
 
 
Figure 36. Ad11 knob alters the surface structure of CD46. (A) Surface representation of 
liganded CD46 SCR1-SCR2, with all residues that interact with Ad11 knob in the complex 
(distance < 4.5 Å) colored in red. Ribbon tracings of the two CD46-binding Ad11 knob 
monomers are shown in blue and green. (B) Surface representation using the structure of 
unliganded CD46 SCR1-SCR2 (Casasnovas et al., 1999). The same residues shown in 
panel A are highlighted in red. Figure made in GRASP (Nicholls et al., 1991). 
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Binding of Ad11 knob to CD46 can be severely impaired by introducing a 
single amino acid change, Arg279 to Gln (Gustafsson et al., 2006). Our structure 
shows that Arg279 is indeed a critical residue, although it does not directly 
interact with CD46. Arg279 is located in the second contact area. Its side chain 
lies directly beneath and parallel to the Arg280 side chain (Figure 32C). The 
Arg279 side chain thus forms a platform that helps to orient Arg280, allowing it to 
engage CD46 residues Glu63 and Phe35. Perhaps of equal importance, Arg279 
also appears to help shape the surface structure of Ad11 knob by forming an 
intra-molecular hydrogen bond linking the HI-and DG-loops (Figure 32C). The 
proximity of Arg279 and Arg280 is somewhat surprising, as both side chains carry 
the same positive charge. In fact, Arg280 occupies a different position in the 
unliganded Ad11 knob structure and only swings next to Arg279 upon complex 
formation (Figure 37). While the amino acids in the DE- and IJ loops have similar 
conformations in the liganded and unliganded Ad11 knob structures, the HI-loop 
exhibits a significant rearrangement of residues that provide clues about the 
determinants of CD46 binding. The most profound conformational 
rearrangement is seen for the Arg280 side chain, which is defined by excellent 
electron density in both structures. In the Ad11-CD46 complex, Arg280 lies 
parallel to Arg279, with the two guanidinium groups stacked against each other 
(Figure 37A). The Arg280 guanidinium group faces towards CD46, forming a salt 
bridge with CD46 residue Glu63, whereas the Arg279 guanidinium group is 
hydrogen bonded to Ad11 residue Asn247. In the unliganded Ad11 knob, the 
Arg280 side chain has rotated about 170 degrees, now facing into the opposite 
direction and pointing away from Arg279 (Figure  37B). Its guanidinium group is 
now stacked against that of the Arg291 side chain. Thus, in both the unbound 
and bound structures, Arg280 is stacked against another arginine, albeit a 
different one on each case. In addition to Arg280, the Ad11 HI-loop residue 
Asp284 also undergoes a rotation as it engages His43 in CD46.  
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Figure 37. Comparison between complexed and uncomplexed Ad11 knobs. (A) Ad11 
knob (blue) complexed with CD46 (red). Amino acids colored yellow are changed upon 
binding to CD46. (B) Ad11 knob uncomplexed. Figure made in PyMOL (DeLano, 2002). 
 
4.2.3 The Ad7 and Ad14 knob 
4.2.3.1 Crystallization of the Ad7 and Ad14 knob 
The knobs of Ad11, Ad14 and Ad7 differ drastically in their ability to bind CD46. All 
three knobs bind better to CHO-CD46 cells than to regular CHO cells, indicating 
that all three knobs are able to interact with CD46 (Gaggar et al., 2003; Marttila 
et al., 2005; Segerman et al., 2003a). However, only Ad11 and Ad14 use CD46 as 
a receptor on human epithelial cells (Marttila et al., 2005), and Ad7 instead binds 
to a different, so far unidentified receptor (Tuve et al., 2006). Despite these 
functional differences, all three knobs are highly similar in sequence: the identity 
between Ad11 and Ad7 knob residues is 93.3 %, whereas the Ad11 and Ad14 
knobs are 92.7 % identical, and the Ad7 and Ad14 knobs are 91.7% identical. 
Thus, these three knobs are ideally suited to define the determinants of CD46 
binding of type B Ads.   
In order to provide a structural basis for the observed differences in CD46 
binding among the three knobs, we first determined the crystal structures of the 
unliganded Ad7 and Ad14 knobs.  Both knobs were crystallized at 20ºC using the 
hanging drop method at a concentration of 10 mg/ml protein. Well-diffracting 
crystals were obtained after 4-7 days (Figure 38A-B), diffracting to 1.75 Å and 1.8 
Å resolution, respectively. After initial screening the final crystallization conditions 
are as follows: Ad7 knob: 23% (w/v) PEG 3350, 0.1 M Hepes pH 7.6; Ad14 knob: 
20% (w/v) PEG 8000, 0.1 M CHES pH 9.0, 200 mM NaCl. The crystals were flash 
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frozen, in reservoir solution supplemented with 25% (w/v) glycerol,  in liquid 
nitrogen and X-ray data were collected at the SLS (Villigen Switzerland) beamline 
X06SA using a MarCCD detector (Ad7 knob) and a Pilatus detector (Ad14 knob).  
 
Figure 38.  Crystals obtained from (A) Ad7 (about 100 x 100 x 100 µm in size) and (B) Ad14 
(about 300 x 300 x 50 µm in size). Crystals were grown using the hanging drop method 
and flash frozen in liquid nitrogen prior to measurements at Beamline X06SA at SLS. 
 
4.2.3.2 Structure solution of the Ad7 and Ad14 knob 
Data for the Ad7 knob were integrated and scaled using the HKL package 
(Otwinowski, 1997), whereas the Ad14 knob data were processed with XDS 
package (Kabsch, 1993) due to incompatibility between the HKL package and 
the Pilatus detector. Initial phases were in each case obtained by molecular 
replacement using trimeric Ad11 knobs from the Ad11-CD46 complex structure 
(Persson et al., 2007) in PHASER (McCoy et al., 2007). Initial rigid body refinement 
of the solutions was performed with CNS (Brunger et al., 1998), and subsequent 
refinement was carried out in REFMAC5 (CCP4, 1994). In both cases the 
structures were refined to excellent R-factors converging at Rwork of 19.2% and 
RFree of 21.2% for Ad14 and Rwork of 20.2% and RFree of 23.8% for Ad7 (Table 4, 
Appendix 7.3). 
 
 
 
 
 
Table 4. Essential crystallographic statistics of the crystallized Ad7 and Ad14 knob. More 
detailed statistics can be found in Appendix 7.3. 
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Data quality Ad7 Ad14 
Space group P21212 P3212 
Unit cell dimensions (Å) a=83.31 b=88.05 c=79.17 a=b=83.31 c=311.71 
Resolution range (Å) 79-1.75 (1.75-1.81) 47.4-1.8 (1.80-1.90) 
Completeness (%) 99.1 (95.1) 99.1 (94.4) 
Redundancy 5.1 (4.6) 11.9 (4.8) 
RMerge(%)1 5.0 (36.4) 7.8 (27.0) 
I/  10.17 (1.34) 11.91 (4.83) 
Refinement statistics   
RWork(%)2 20.2 19.2 
RFree(%)2 23.8 21.2 
Highest-resolution shell is shown in parentheses.  
 
1-Defined in the Methods section 3.7.7 
2-Defined in the Methods section 3.7.10 
Free set contains 10% of reflections (see Methods section 3.7.10). 
 
4.2.3.3 Alignment of the Ad7, Ad11 and Ad14 knobs 
All three sequences can be aligned without gaps (Figure 39A), suggesting that 
differences among them are primarily a result of altered properties due to 
individually substituted amino acids, rather than larger conformational changes 
in surface loops (using T-coffee at www.ch.embnet.org) (Notredame et al., 
2000). We therefore used the Ad11 structure to map substitutions in Ad7 and 
Ad14 onto its surface. Perhaps not unexpectedly, most substitutions are located 
along the CD46 contact area, clustering in the loops responsible for the contacts 
(Figure 39B). Arg279, which has been identified as a key determinant of CD46 
binding, is replaced with Gln in both Ad7 and Ad14. Moreover, Asp284, which 
also contacts CD46 in Ad11, is also replaced in both Ad7 and Ad14. 
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Figure 39. Comparison of Ad11, Ad14 and Ad7 knobs. (A) Alignment of Ad11, Ad14 and 
Ad7 fiber sequences. Amino acid substitutions are colored in red for substitutions in Ad14 
and Ad7, orange for substitutions in Ad14 and green for substitutions in Ad7. The 
sequence of the shaft is colored gray and the loops involved in interactions with CD46 
boxed in blue. (B) Mapping of the substituted amino acids upon the surface of Ad11 
knob. Most of the interacting amino acids can be found along the binding epitope of 
CD46. For simplification, just one copy of CD46 is shown even though one Ad11 knob 
trimer binds three copies of CD46. Figure B made in PyMOL (DeLano, 2002). 
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4.2.3.4 Structure comparison between the Ad7, Ad11 and Ad14 knobs 
As already suggested by the high sequence similarity, the overall structures of the 
three knobs are almost identical. Ad7 and Ad14 can be superimposed on Ad11 
with an r.m.s. deviation of 0.3-0.4 Å using all Cα atoms (Ad7 protomer 0.218 Å 
and Trimer 0.296 Å; Ad14 protomer 0.445 Å and Trimer 0.387 Å). Differences are 
seen in surface exposed loops, with minor changes in the HI-loop (Figure 40A), 
DE-loop and IJ-loop, which also make contacts in the Ad11-CD46 complex 
structure. The HI- and DG-loops are bridged in Ad7 and Ad14 by a water 
molecule connecting Gln279 and Asn245, forming essentially the same structure 
as in the Ad11 knob. An interesting feature is the identical anti-parallel stacking 
of the Arg280-Arg291 pair in the Ad7, Ad11 and Ad14 knobs (Figure 40B-D).  
 
 
Figure 40. Comparison of the X-ray structures of the Ad11, Ad7 and Ad14 knobs. (A) 
Superimposition of the Ad11 (blue), Ad7 (yellow) and Ad14 (green) knobs. (C-D) Close-up 
views of the HI-loops of the Ad11, Ad7 and Ad14 knobs, respectively. Figure made in 
PyMOL (DeLano, 2002). 
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4.2.3.5 Ad11 but not Ad7 and Ad14 block binding of S35-labelled Ad11 
particles 
Given their similarities in sequence, we performed a binding assay to determine 
whether each of the three knobs can compete for Ad11 binding to human 
respiratory cells. This assay was done at the University of Umeå in collaboration 
with Dr. Niklas Arnberg (see Methods section 3.6).  
As expected, binding of 35S-labeled Ad11 was substantially reduced upon 
preincubation with Ad11 knobs (Figure 41A). Interestingly, neither Ad7 nor Ad14 
knobs were able to compete efficiently with binding of 35S-labeled Ad11 virions. 
However, soluble Ad7 and Ad14 knobs efficiently blocked 35S-labeled Ad7 
particles (Figure 41B). 
 
Figure 41. Binding experiments performed on A549 cells. Soluble knobs were incubated 
with A549 cells prior to addition of 35S-labeled (A) Ad11 particles or (B) Ad7 particles. 
Values are given as percent of total CPM. Soluble Ad11 knobs blocks Ad11, Ad14 and 
Ad7 but neither Ad14 or Ad7 blocked Ad11. Interestingly, soluble Ad14 and Ad11 
blocked Ad7. The data indicate that all tested knobs use similar epitopes on CD46 for 
binding.  
Results 
 87 
4.2.3.6 Ad7 and Ad14 knobs bind CD46 with a 3000-fold lower affinity 
compared with the Ad11 knob 
The binding experiments indicated that the Ad11 and Ad7/Ad14 knobs bind 
either different epitopes of, or have very different affinities for, CD46 (see Results 
section 4.2.3.5). In order to more precisely measure the affinities of all three knobs 
for CD46, we carried out SPR experiments using the BiaCore™ 2000 system. These 
experiments were performed by Steffen Müller (Interfaculty Institute for 
Biochemistry) and interpredet jointly. Each interaction was measured in 
duplicates followed by two control injections to verify a constant surface during 
the entire measurement. Kinetic constants could be extracted from the Ad11 
knob data set (Figure 42A) but not for the Ad7 and Ad14 knobs due to their fast 
Kon and Koff rates (Figure 42B-C). Knob affinities were measured for both CD46 
SCR1-SCR2 and CD46 SCR1-SCR4. The knobs had the similar affinities for CD46 
SCR1-SCR2 and CD46 SCR1-SCR4, which were in the range of 12 nM for the Ad11 
knob and 33 µM for the Ad7 and Ad14 knobs (Table 5). Thus, the Ad7 and Ad14 
knobs bind to CD46 with a 3000-fold lower affinity. Since all knobs have a similar 
affinity for both CD46 fragments, our data confirm that only the SCR1-SCR2 
region of CD46 interacts with the Ad knobs. At least for the Ad11 knobs, this is 
consistent with the structure of the complex with CD46, which is based on a 
binding surface formed by the SCR1-SCR2 region. 
 To elucidate if Ad11 and Ad7/Ad14 use the same epitopes for binding 
CD46 we designed a series of SPR experiments that were performed in solution 
(Adamczyk et al., 1998). A chip coated with the Ad35 knob, which previously 
had been shown to bind CD46 (Fleischli et al., 2005; Gaggar et al., 2005) (see 
Materials section 2.2.6 and Appendix 7.1), was used with a constant 
concentration of CD46 SCR1-SCR2 or CD46 SCR1-SCR4 as the analyte. The 
affinity of Ad11 and Ad35 knobs for CD46 is similar (see following section) Several 
datasets were collected using increasing concentrations of Ad11, Ad7 or Ad14 
mixed with the constant concentration of CD46 competing with the Ad35  knobs  
on the coated surface for binding to CD46. As the concentrations of the Ad11, 
Ad7 or Ad14 knobs increased the RU signal diminished indicating similar binding 
epitopes between for example the Ad11 and Ad35 knobs. However, the signal 
for the Ad11 knob diminished faster than the one for the Ad7 and Ad14 knobs 
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due to the higher afnity for CD46. Multiple datasets allowed us to conclude that 
Ad11, Ad7 and Ad14 use partially overlapping or completely overlapping 
epitopes on CD46 for binding.  
 
 
Figure 42. Examples of collected BiaCore data for (A) Ad11 binding to CD46 SCR1-SCR2, 
(B) Ad7 binding to CD46 SCR1-SCR2 and (C) concentrations of CD46 plotted against RU 
for the Ad7 dataset. The Ad11 affinity for CD46 SCR1-SCR2 was determined to 12 nM and 
the Ad7 affinity for CD46 SCR1-SCR2 to 33 µM. Experiments performed by Steffen Müller 
(Interfaculty Institute for Biochemistry, Tuebingen).  
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Table 5. Determination of Ad knob affinity for CD46 SCR1-SCR2 and CD46 SCR1-SCR4. 
Experiments performed by Steffen Müller (Interfaculty Institute for Biochemistry, 
Tuebingen). 
 
Protein interaction Steady-
State-
Analysis 
Kinetic Analysis Solution 
affinity 
Analysis 
Immobilized 
knob 
in solution KD [M] KD 
[M] 
kon  [M-1s-1] koff [s-1] KD [M] 
Ad11 CD46 
SCR1-SCR2 
n.d. 11 e-
09 
1.3 e06 0.014 23 e-09 
Ad11 CD46 
SCR1-SCR4 
n.d. 13 e-
09 
0.8 e06 0.009 19 e-09 
Ad7 CD46 
SCR1-SCR2 
35 e-06 58 e-06 
Ad7 CD46 
SCR1-SCR4 
30 e-06 65 e-06 
Ad14 CD46 
SCR1-SCR2 
27 e-06 73 e-06 
Ad14 CD46 
SCR1-SCR4 
31 e-06 
Not determined because of 
extremely high off rates. 
63 e-06 
4.2.4 Mutation study of the CD46 SCR1-SCR2: Ad11 
knob interaction 
The major interactions in the complex between Ad11 and CD46 SCR1-SCR2 are 
located in the HI-loop, as previously described (see Results section 4.2.2.4). We 
characterized the interaction by introducing mutations using overlap extension 
PCR (see Methods section 3.1.1). Ad11 amino acids responsible for interactions 
with CD46 were mutated one by one, and the affinity was measured using ITC 
(see Methods section 3.5.1 and Appendix 7.2). To verify that the observed 
change in affinity was not due to major structural rearrangements of the epitope 
we also crystallized the mutant knobs. We mutated the amino acids as follows; 
N245S, R279Q, R279S, R280G, I282L, N283S and D284S (Figure 43). We also made a 
“rescue mutant” of Ad7 mutating Q279 to Arg, in order to restore the high affinity 
of the Ad7 knob for CD46. 
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Figure 43. Cartoon representation of the Ad11 kno:CD46 complex. CD46 is shown in red 
and the Ad11 knob in blue. The green circles indicate amino acids of Ad11 that were 
selected for mutagenesis. Figure made in PyMOL (DeLano, 2002). 
 
4.2.4.1 Affinity measurements 
Initially, the mutants were screened for altered binding capacity to CD46 using 
our gel filtration assay (using analytical columns and a Smart system, GE 
Healthcare; data not shown); later, affinity was determined using ITC. However, 
some mutant knobs have also been measured using SPR due to the higher 
sensitivity of the method (Table 6). The mutant Ad11-N245S was just analyzed 
using the gel filtration assay. Previous observations have shown that mutating 
Ad11-R279 to Gln significantly reduces the knob binding to CD46 expressing cells 
(Gustafsson et al., 2006). Only a strong reduction was detected, and not a 
complete loss of binding. Gustafsson et al. also made the rescue mutant of Ad7 
(Gln to Arg), which restored the binding to about 50%. We performed similar 
experiments, mutating the two amino acids, and measured the affinity for CD46 
using ITC and SPR. Surprisingly, Ad11-R279Q, and Ad11-R279S, had no affinity for 
CD46 measured by ITC but a µM affinity in SPR. The affinity measured using SPR 
correlates with the published data for the Ad11 knob mutants as well as for the 
rescue mutant (Ad7-Q279R) (Gustafsson et al., 2006).  The restored affinity is in the 
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higher nM, range indicating that Arg279 is the key for high affinity, but that the 
entire loop helps in building the tight interaction (Figure 44). In Figure 44, the 
Ad35 knob (see Results section 4.2.5) is also included as its affinity is almost 
identical to that of the Ad11 knob (Tuve et al., 2006). 
 
 
Figure 44. Evaluation of all available affinity data collected using SPR. The red arrow 
indicates loss of affinity for Ad11 upon mutation of Arg279 to Gln and the green arrow 
indicates increased affinity for CD46 upon mutating Ad7-Gln279 to Arg. The loss, or gain, 
of affinity is about 50%.  Figure generously provided by Steffen Müller (Interfaculty Institute 
for Biochemistry, Tuebingen). 
 
 
By mutating Ad11-I282L, a three-fold decrease in affinity for CD46 was observed 
using ITC. Thus, Ad11-R279Q/S and Ad11-I282L are the only mutations that 
displayed an altered affinity in our ITC setup. With the higher sensibility in SPR 
there could still be minor differences in affinity that we could not detect. The 
data indicate that the amino acid present at position 282 is the second most 
important, after position 279, for determining the affinity for CD46. 
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Table 6. Affinity of Ad11 mutants for CD46 measured using ITC and BiaCore. Experiments 
performed by Steffen Müller (Interfaculty Institute for Biochemistry, Tuebingen). 
 
Protein interaction BiaCore 
affinity 
Solution affinity 
analysis 
ITC affinity 
analysis 
Structure 
determined 
Knob CD46 KD [M] KD [M] KD [M] Resolution (Å) 
Ad11-N245S CD46 
SCR1-2 
n.d n.d n.d 1.6 
Ad11-R279Q CD46 
SCR1-2 
1.5 e-06 0.8 e-06 None 2.55 
Ad11-R279S CD46 
SCR1-2 
n.d n.d None n.d 
Ad11-I282L CD46 
SCR1-2 
n.d n.d 6.8 e-09 1.8 
Ad11-N283S CD46 
SCR1-2 
n.d n.d 1.8 e-09 1.72 
Ad11-D284S CD46 
SCR1-2 
n.d n.d 1.8 e-09 n.d 
Ad11-R280G CD46 
SCR1-2 
n.d n.d None n.d 
Ad7-Q279R CD46 
SCR1-2 
0.5 e-06 0.1 e-06 n.d 1.55 
 
4.2.4.2 Crystallization of mutant knobs 
During the crystallization trials not all mutants gave well-diffracting crystals. The 
mutated knobs for which crystals could be grown were crystallized using the 
hanging drop method at 20 ºC, and crystals were obtained after one week. 
These knobs were crystallized over a reservoir solution as follows: Ad11-I282L 20% 
(w/v) PEG 3350 0.2 M Hepes pH 7.4, Ad11-N283S 30% (w/v) PEG3350 0.2 M Tris pH 
7.0, Ad11-N245S 16% (w/v) PEG 6000 0.2 M MES pH 6.1, Ad11-R279S 25% (w/v) 
PEG3350 0.2 M Tris pH 7.0, Ad7-Q279R 26% (w/v) PEG3350 0.2 M Tris pH 8.0. Data 
for all the crystallized knobs were collected at beam line X06SA at SLS and 
refined to excellent statistics using Refmac5 (CCP4, 1994) after scaling and 
integration using the HKL package (Otwinowski, 1997) (Table 7 and Appendix 
7.3). 
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Table 7. Essential crystallographic statistics for the five crystallized mutant knobs. More 
detailed statistics can be found in Appendix 7.3. 
 
Data quality Ad11-
I282L 
Ad11-N283S Ad11-N245S Ad11-R279S Ad7-Q279R 
Space group I23 I23 I23 P32 P21212 
Unit cell 
Dimentions (Å) 
a=102.63  
 
a=101.41 
 
a=101.66 
 
a=b=148.65 
c=74.44 
a=83.13 
b=87.8 c=79.1   
Resolution  
Range (Å) 
72.6-1.8 
(1.8-1.86) 
71.8-1.72 
(1.72-1.78) 
71.8-1.6 
(1.6-1.66) 
129-2.55 
(2.55-2.64) 
79.06-1.55 
(1.55-1.61) 
Completeness  
(%) 
98.23 
(86.2) 
99.74 (99.4) 99.9 (100) 98.97 (98.1) 98.2 (95.8) 
Redundancy 16.8 (1.66) 6.2 (2.7) 7.3 (7.1) 3.2 (2.9) 5.4 (5.3) 
RSym(%)1 6.4 (38.2) 8.5 (38.2) 7.4 (44.0) 9.7 (38.9) 6.3 (38.9) 
I/  7.2 (5.7) 16.65 (1.22) 14.2 (1.8) 7.42 (1.2) 12.8 (1.4) 
Refinement 
statistics 
     
RWork(%)2 20.6 17.8 19.4 21.3 23.1 
RFree(%)2 23.8 22.2 22.0 23.6 25.4 
Highest-resolution shell is shown in parentheses. 
 
1-Defined in the Methods section 3.7.7 
2-Defined in the Methods section 3.7.10 
Free set contains 5-10% of reflections (see Methods section 3.7.10). 
 
 The overall folds of the mutant knobs are identical to that of the wt. The 
conformation of some loops differs slightly in the area close to the mutation, 
mostly around the HI- and DG-loops (Figure 45).  Observed alterations in affinity 
can thus be connected to the mutated amino acid and not an altered overall 
conformation. In Figure 45, the mutations Ad11-N283S and Ad11-N245S are not 
included, since the loops were not significantly changed in comparison to the 
Ad11 knob. 
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Figure 45. Close-up view of the HI-loop, with superimposed structures of knobs of Ad11 
(blue), Ad7 (yellow), Ad11-R279S (green), Ad11-I282L (red) and Ad7-Q279R (wheat). All 
five proteins superimpose very well. Changes are seen in the distance between the two 
loops, suggesting that the mutations distort the overall shape of the epitope, thus 
affecting the affinity. Figure made in PyMOL (DeLano, 2002). 
 
4.2.4.3 Ad11-I282L 
The mutation Ad11-I282L places the amino acid of the corresponding Ad7 knob 
at position 282 (Figure 46A). Even though this amino acid of Ad11 is not directly 
involved in interactions to CD46, in our complex structure, it could be of 
importance due to its hydrophobic properties. The electron density is excellent in 
the entire loop. 
4.2.4.4 Ad11-N283S 
The entire loop has very well defined electron density (Figure 46B). By mutating 
Ad11-N283S, the hydrogen bond between CD46-H43 and Ad11-N283 should be 
abolished. This amino acid is conserved between the Ad11 and the Ad7 knob. 
This mutation will thus not indicate why Ad7 binds CD46 with a much lower 
affinity. It was made to define key residues of the interaction of the Ad11 knob 
with CD46. The overall fold of the knob is identical, with only minor alternations in 
the HI-loop.  
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4.2.4.5 Ad11-N245S 
The Ad11-N245S mutants was analyzed based on the hypothesis that the 
hydrogen bonding between Ad11-N245 and Ad11-R279 would stabilize the 
position of the Arg, locking the DG- and HI-loop down and creating the crucial 
platform for CD46 binding. The density for the mutated amino acid is excellent, 
as well as for all other amino acids in close proximity (Figure 46C). The position of 
the loop is not altered and the affinity measured using ITC is identical to the wt 
knob.  
 
Figure 46. Close-up view of the HI-loop in (A) Ad11-I282L, (B) Ad11-N283S and (C) Ad11-
N245S knobs, with the corresponding 2Fobs-Fcalc electron density maps at a contour level 
of 1 σ . Figure made in PyMOL (DeLano, 2002). 
 
Results 
 96 
4.2.4.6 Ad11-R279S 
The biggest impact on the relative orientation of the HI- and DG-loops was 
observed when Ad11-R279 was mutated to a Ser. The distance between the HI- 
and DG-loop is significantly increased. The mutation abolishes the interaction 
between the HI- and the DG-loop (Figure 47A and Figure 32C). Even though the 
mutant protein crystals diffracted less well, the structure is still reliable, with good 
statistics (Table 7 and Appendix 7.3) and clear electron density. Most likely, a 
high affinity interaction is not possible due to altered surface complementarity.  
4.2.4.7 Ad7-Q279R 
The structure of the “rescue” mutant of Ad7, which binds CD46 with high affinity, 
could be determined with excellent statistics (Table 6 and Appendix 7.3). In the 
crystal structure, the stabilization of the two loops is identical to the Ad11 wt knob 
(Figure 47B). Interestingly, the mutation of Ad7-Gln279 to Arg does not affect the 
orientation of the two loops, just the affinity for CD46. 
 
 
Figure 47. Close-up view of the HI-loop in (A) Ad11-R279S and (B) Ad7-Q279R with the 
corresponding 2Fobs-Fcalc electron density maps at a contour level of 1 σ. Figure made in 
PyMOL (DeLano, 2002). 
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4.2.5 Structural and functional characterization of 
Ad35 knobs 
4.2.5.1 Expression of Ad35 knobs 
The Ad35 and Ad35short knob proteins were expressed and purified as described 
in the Methods sections 3.3 and 3.4. Both knobs were functionally active as 
judged by the ability to bind CD46 in our gel filtration assay (data not shown).  
4.2.5.2 Affinity studies of the Ad35 interaction with CD46 
We measured the affinity between the Ad35 knob and both CD46 fragments 
using ITC and SPR. Our results show that the Ad35 knob affinity for CD46 is about 
14 nM, the average of two measurements (Table 8 and Figure 44), and therefore 
similar to that of the Ad11 knob-CD46 interaction. As with the other knobs, the 
affinity does not differ between the two forms of CD46. Furthermore, epitope 
mapping experiments in solution indicate that the Ad35 knob-binding epitope of 
CD46 overlaps with the one used by the Ad11, Ad7 and Ad14 knobs. We 
therefore conclude that, like the other strains, Ad35 binds exclusively to the N-
terminal two domains of CD46, SCR1-SCR2. This was also shown previously 
(Fleischli et al., 2005; Gaggar et al., 2005).    
   
Table 8. Affinity measurements of the interaction between Ad35 knob and CD46. 
Experiments performed by Steffen Müller (Interfaculty Institute for Biochemistry, 
Tuebingen). 
 
Protein interaction Steady-
State-
Analysis 
Kinetic Analysis Solution 
affinity 
Analysis 
ITC 
Affinity 
immobilized in 
solution 
KD [M] KD [M] kon  [M-1s-
1] 
koff [s-1] KD [M] KD[M] 
Ad35 knob CD46-
SCR1-2 
n.d.  
17 e-09   
11 e-09 
17 e-09 
3.4 e06 
1.5 e06 
0,036 
0,025 
19 e-09 3.5e-9 
4.5e-9 
Ad35 knob CD46-
SCR1-4 
n.d.  
17 e-09   
11 e-09 
17 e-09 
3.4 e06 
1.5 e06 
0,036 
0,025 
27 e-09 n.d 
 
4.2.5.3 Crystallization of the Ad35 knob 
The affinities of the Ad11 and Ad35 knobs for CD46 are similar. However, 
sequences of the two knobs are not especially well conserved, even in the area 
of the Ad11 knob that engages CD46. Still, the similar behavior of the two knobs 
with respect to binding CD46 suggests that some variation in sequence, and 
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possibly surface structure, of CD46-binding residues can be tolerated. We 
therefore set out to initiate structural studies of the Ad35 knob alone and in 
complex with CD46. We performed extensive crystallization trials with the longer 
Ad35 knob protein comprising amino acids 118-325 (see Methods section 2.2.6) 
at 20 ºC as well as 4 ºC, and several different crystal forms were obtained. 
Unfortunately, all crystal forms diffracted relatively poorly. The best crystals 
diffracted only to about 3.8 Å (Table 9). Although a structure determination at 3.8 
Å resolution is possible, it was not pursued since the crystals had an extremely 
large unit cell that contained between 10 and 15 copies of the Ad35 knob 
trimers as estimated by the Matthews coefficient (Matthews, 1968). In the 
meantime, the crystal structure of an Ad35 knob was solved by others, to a 
resolution of 2.0 Å (Wang et al., 2007). Interestingly, this published crystal structure 
was obtained from a crystallization condition that is similar to one with which we 
also obtained crystals. However, our crystals did not diffract well, probably 
because our protein had five extra N-terminal amino acids that were not present 
in the protein crystallized by Wang et al. Very likely, these N-terminal amino acids 
impede crystallization.  
4.2.5.4 Crystallization of the Ad35 knob:CD46 complex  
In order to define the interaction between the Ad35 knob and CD46, we also 
pursued the crystallization of this complex. Purification was done using the 
approach described in detail for the purification of the Ad11 knob-CD46 
complex in the Methods section 3.4.3. We performed extensive crystallization 
trials with the longer version of the Ad35 knob in complex with CD46 SCR1-SCR2, 
and obtained several crystal forms that all diffracted very poorly, to about 7 Å. 
However, once the crystal structure of a shorter version of the Ad35 knob was 
published (Wang et al., 2007), we decided to test whether using this construct 
would produce better-diffracting crystals of the complex with CD46. 
Unfortunately, while we were able to also produce crystals of the complex, they 
did not diffract beyond 7 Å and thus did not allow us to determine the structure. 
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Table 9. Essential crystallographic statistics for the Ad35 knob. 
 
Data quality Ad35 
Space group P212121 
Unit cell 
Dimentions (Å) 
a=166.92 b=186.63 c=314.56 
 
Resolution  
Range (Å) 
40-3.8 
(3.8-3.94) 
Completeness  
(%) 
94.2 (88.6) 
Redundancy 6.9 (7.2) 
RSym(%)1 12.9 (45.8) 
I/  6.22 (1.95) 
Highest-resolution shell is shown in parentheses. 
1-Defined in the Methods section 3.7.7 
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5 Discussion 
5.1 Interactions of pathogens with CD46 
Understanding the precise mode of interaction with cellular receptors is essential 
for revealing the mechanism of viral pathogenesis, and also for the development 
of novel antiviral agents as well as vaccines. Several groups of pathogens use 
CD46 as a cellular receptor. Measles virus binds to the two most membrane 
distant repeats, SCR1 and SCR2 (Casasnovas et al., 1999), while human herpes 
virus 6 binds to SCR2 and SCR3 (Greenstone et al., 2002). In addition, Neisseria 
gonorrhoeae pili bind to SCR3 and the STP region (Kallstrom et al., 2001), whereas 
the M protein from streptococci A strains binds to SCR3 and SCR4 (Giannakis et 
al., 2002). We used a combination of functional and structural studies to 
characterize the interaction between several species B Ads and CD46. We find 
that the interaction of CD46 with Ads is most similar to that reported for measles 
virus, as in both cases the same region of the receptor (domains SCR1 and SCR2) 
is used. The observed interactions could easily occur in the context of an entire 
virus particle and a cell surface bearing CD46. Both the measles virus 
hemagglutinin and the Ad fiber are large, multimeric proteins and thus 
interaction with the outermost, membrane-distal region of CD46 may be 
preferred in both cases. Thus, the results presented in this thesis have relevance 
also for the interactions of CD46 with other pathogens. 
5.2 Structure of the Ad11 knob:CD46 
complex 
5.2.1 Implications of the structure 
We solved the structure of the knob of Ad11, a member of the species B Ads, in 
complex with CD46 SCR1-SCR2 to a resolution of 2.85 Å by X-ray crystallography. 
CD46 binds two Ad knob protomers, making more extensive contacts with one of 
them. The area of CD46 that is recognized by the Ad11 knob is exposed and 
distant from the membrane, and could easily be engaged by an approaching 
knob. A striking feature in the complex is the surface complementarity, occluding 
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a total of 1600Å2 from solvent. In the crystal structure of ligand-free CD46 SCR1-
SCR2, an angle of ~60º was observed between SCR1 and SCR2. Since a similar 
angle was present in multiple copies of the protein and in two crystal forms, the 
bent shape is unlikely to be a crystallization artifact but rather represents the 
conformation of the unliganded protein at the cell surface. The Ad11 knob binds 
to the interface between SCR1 and SCR2 making contacts to both repeats, thus 
reshaping CD46 and causing it to adopt an elongated rod like shape (Persson et 
al., 2007). The Ad11 affinity for CD46 was measured using ITC and is in the range 
of 2 nM, and thus about 10 fold higher than the interaction between Ad5 and its 
receptor CAR (Kirby et al., 2000).  
Interactions in the complex involve a large number of residues. About 50% 
of contacts are mediated through backbone atoms, hinting at a potential 
strategy that allows the virus to alter its surface structure through mutation 
without affecting its interaction with CD46. The long and flexible HI and DG loops 
are stabilized by hydrogen bonds between Arg279 and Asn247/Gln250 
respectively, which form a platform for CD46 binding. A key observation is a 
parallel stacking of the guanidinium groups of Ad11 arginines Arg279 and 
Arg280, in the immediate vicinity of CD46 residue Phe35. The positioning of the 
two arginine side chains would be expected to be non-favorable as the two 
positively charged guanidinium groups would repel each other. However, non-
covalent interactions, such as the Arg-Arg stacking, can be important in 
determining the structure and function of proteins. A similar interaction to the 
Arg-Arg stacking is the cation-π interaction, which is increasingly recognized as 
an important non-covalent interaction determining drug specificity and protein 
function (Gallivan and Dougherty, 1999). Energetically, a typical cation-π 
interaction can be stronger than a normal salt bridge (Zacharias and Dougherty, 
2002), and it is often observed between guanidine groups of Arg and aromatic 
ring systems in, for example, tyrosines or tryptophans (Burley and Petsko, 1986). 
The delocalized electrons of the aromatic ring act as hydrogen bond acceptors, 
and can accept hydrogens from the –NH3 group in the arginine sidechain 
(Flocco and Mowbray, 1994). The interaction has effects on the pK value of 
neighboring amino acids, thus altering the charge distribution. As the stacking 
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probably affecs the pK values in the direct environment it is plausible to assume 
that one of the two arginines is deprotonated even though the pk value for 
isolated arginines is very high (Flocco and Mowbray, 1994). Most likely, Arg279 is 
deprotonated as Arg280 directly interacts with Glu63 in CD46 and therefore likely 
keeps its charge. 
Interestingly, an additional Arg-Arg stacking is observed in the structure of 
the uncomplexed Ad11 knob which we determined to high resolution. In this 
case, the guanidinium groups of Arg280 and Arg291 are stacked on top of each 
other. The stacking is anti-parallel and almost perfectly planar, with an average 
distance of 3.9 Å between atoms facing each other. The Arg-Arg stacking may 
act as a molecular switch. Arg280 is stacked against Arg291 in the unbound 
knob (off-position), whereas it is stacked against Arg279 in the structure of the 
Ad11 knob in complex with CD46 (on-position). 
5.2.2 Comparison with the Ad35 knob 
Ad11 and Ad35 both use CD46 as a receptor. The crystal structure of the Ad35 
knob was recently published (Wang et al., 2007). Both structures superimpose 
very well, suggesting that a conserved mode of interaction with CD46 exists 
between Ad11 and Ad35 (Figure 48). The affinity of both knobs for CD46 is in the 
same range of 12 nM (measured using SPR). It is noteable, though, that the Ad35 
knob lacks the Arg-Arg stacking observed in the uncomplexed Ad11 knob 
structure. The amino acid corresponding to Ad11 Arg280 is Arg279 in Ad35. This 
amino acid is already in the “on-position” and thus appears to be readily 
available for the cation-π interaction with CD46-Phe35. It appears that the “off-
position” in Ad35 is not favored for Arg279 as there is no arginine equivalent to 
the Ad11-residue Arg291 in the Ad35 knob. We are currently working on the 
crystallization of CD46 in complex with the Ad35 knob in order to define the basis 
of interaction for this Ad type. 
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Figure 48. Comparison of the structures of the Ad11 knob, the Ad11 knob:CD46 complex 
and the Ad35 knob. (A) Superimposition of the unliganded Ad11 knob (blue), liganded 
Ad11 knob (green), and unliganed Ad35 knob (yellow). (B) Close-up view of the HI-loop 
using the same superposition.  
 
5.2.3 Comparison with the Ad12-knob:CAR complex 
The location and architecture of the CD46-binding surface is completely distinct 
from that used by other Ads to bind to CAR (Figure 49). The structure of the 
complex between the Ad12 knob and the N-terminal domain of CAR (CAR-D1) 
(Bewley et al., 1999) shows that CAR binds at a region near the AB-loop of the 
Ad12 knob. The AB-loop is located on a different face of the knob, almost 
exactly opposite from the site of CD46 attachment. Ads therefore appear to 
have evolved to bind different receptors not by subtly modifying one binding 
surface but by creating an alternative site while deconstructing the first. Non-
CAR binding Ads typically carry an insertion in the AB-loop, which likely helps to 
prevent binding to CAR. Conversely, CAR-binding Ads have very short DG- and 
HI-loops, eliminating most of the possible contact points for CD46. Significantly, 
the mode of binding is different as well. The CAR-binding surface of Ad12 
features several discrete, smaller contact points separated by large solvent-filled 
cavities (Bewley et al., 1999), whereas the CD46-binding surface of Ad11 knob is 
extensive, continuous, and devoid of solvent molecules.  
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Figure 49. Comparison of the mode of interaction of Ad knobs with CAR and CD46.  The 
structures of the Ad12 knob-CAR (Bewley et al., 1999) and Ad11 knob-CD46 complexes 
were superimposed using all corresponding Ad knob residues. Only one Ad knob 
monomer is shown in each case, although a second monomer also contributes some 
contacts in both complexes. The N-terminal domain of CAR (D1) binds to a surface that 
mostly involves the AB-loop of the Ad12 knob monomer, whereas CD46 lies across a 
platform that is formed by the DG- and HI-loops of Ad11 knob. CAR is drawn in pink, the 
Ad12 knob in yellow, the Ad11 knob in blue, and CD46 SCR1-SCR2 in red. The glycans 
and disulfide bonds of CD46 are shown in yellow. 
 
5.2.4 Comparison with the Ad37-knob:sialic acid 
complex 
The Ad37 knob has been reported to bind to CD46, CAR, as well as α2,3-sialic 
acid (Arnberg et al., 2000a; Burmeister et al., 2004). However, superimposition 
with the Ad11 knob indicates that if the Ad37 knob binds CD46, it must do so with 
different epitopes that those seen in the Ad11-CD46 complex. The HI- and DG-
loops in the two proteins are rather different, with the HI-loop of the Ad37 knob 
having a drastically altered conformation that would preclude engagement of 
CD46 as we see it in the structure of the complex produced with the Ad11 knob. 
Interestingly, the shaft length of the fiber is shorter in the D-types that bind sialic 
acid (Ad9, Ad19 and Ad37), and also in the B types. Published data indicate that 
a high flexibility of the shaft is required for an interaction with CAR since CAR is a 
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component of tight junctions and thus may not be accessible by fibers with a 
more rigid, shorter shaft (Wu et al., 2003). The sialic acid binding knobs and the 
CD46 binding knobs could therefore share a common ancestor that had a 
shorter shaft and did not bind to CAR. From this ancestor, knobs binding sialic 
acid may have evolved by creating a positively charged region at the top of the 
knob that interacts with sialic acid, and knobs binding CD46 may have evolved 
towards forming a shorter HI-loop that would allow for interactions with CD46. This 
could also be one explanation for the observations that Ad37 binds CD46 (Wu et 
al., 2004), since some shared features could remain that under optimal 
conditions may allow an interaction with CD46, probably via a mechanism that is 
different from the one seen in the Ad11 knob complex. 
5.3 Interactions of Ad7 and Ad14 with CD46 
At the outset of our study, it was unclear whether Ad7 binds to CD46 or not. The 
literature on this topic is not conclusive as some authors reported that Ad7 does 
bind (Fleischli et al., 2007), whereas other studies reported that CD46 does not 
serve as a receptor for Ad7 (Marttila et al., 2005; Segerman et al., 2003b). We 
therefore decided to investigate if Ad7 can interact with CD46 using SPR and, 
secondly, if the binding can be blocked by soluble knobs in a binding assay 
using radioactive virions. At the same time we investigated the binding 
characteristics of Ad14, which is highly homologous in sequence to both Ad7 
and Ad11. We find that both the Ad7 and Ad14 knobs bind CD46 with an affinity 
in the range of 30 µM. However, the interaction occurs in a very fast, square 
wave like mode. Although the affinity is well within the range for a productive 
interaction, the kinetics suggest that is it unlikely that these two knobs bind CD46 
in vivo as the complexes form only transiently and fall apart quickly. The most 
likely explanation of this binding behavior is that key residues for a stable 
interaction are missing. The two molecules engage each other and dissociate 
from each other so quickly that there would most likely not be enough time for 
the secondary interaction with cell-surface integrin receptors that triggers 
uptake. It is certainly possible that CD46 functions as a cellular receptor for Ad7 
and Ad14, on certain cell types and under optimal conditions. These conditions 
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could be hard to reproduce in an in vitro setup. In addition, CD46 could function 
as an adhesion-strengthening receptor that is either only engaged once the 
primary receptor, such as the receptor X described by Tuve et.al., 2006,  is 
engaged, or that facilitates the engagement of  receptor X. It is also possible 
that Ad7 binds to CD46 but fails to elicit the structural change between SCR1 
and SCR2. Without this change, a high-affinity interaction can not occur as the 
surface of both SCR1 and SCR2 contribute residues to the interface with Ad 
knobs.  
The blocking experiment indicates that the three types share the same 
epitope for binding to CD46. Soluble Ad11 knobs effectively blocked the binding 
of both radioactively labeled Ad11 and Ad7 particles. However, soluble Ad7 and 
Ad14 knobs did not block the attachment of radioactively labeled Ad11 virions. 
Even with high concentrations of Ad11 total blocking could never be observed, 
most likely due to unspecific binding or the engagement of a secondary 
receptor (Wickham et al., 1990). The amount of unspecific binding varies 
between cell types and virus strains. A more efficient inhibition can probably be 
achieved by measuring infectivity, where productive interactions alone are 
quantified. The observed much faster interaction between Ad7/Ad14 and CD46 
could explain why Ad7 and Ad14 knobs do not block the binding of Ad11 
particles. Due to the much higher turnover of the Ad7/Ad14 interaction, Ad11 
particles will accumulate on the surface of the cell. During washing more of the 
Ad7/Ad14 knobs or particles will thus be washed away. The observed difference 
in the binding experiment between Ad11 and Ad7/Ad14 could be due to the 
experimental setup.  
Our data indicate that all three knobs bind CD46 using partially, or 
completely, overlapping epitopes our results do not answer ithe question 
whether the Ad7 and Ad14 interaction with CD46 is physiologic, leading to 
replication of viral genes. 
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5.4 The crystal structures of the Ad7 and 
Ad14 knob 
In order to define the structural basis for CD46 binding, structures of Ad7 and 
Ad14 knobs were determined. Both knobs are similar in sequence to the Ad11 
knob but bind CD46 with drastically different affinities and kinetics. Both structures 
were determined at high resolution and thus possess high accuracy. The two 
structures superimpose very well with the unliganded structure of the Ad11 knob. 
The anti-parallel stacking of Arg280 and Arg291, which was observed in the 
unliganded Ad11 knob structure, is present in both Ad7 and Ad14. Thus, Arg280 is 
in the “off position” in all three unliganded knobs. Interestingly, Ad11 residue 
Arg279, which stabilizes the Arg280 side chain in the “on position” in the complex 
with CD46, is replaced with a glutamine in both Ad7 and Ad14 knobs. Since a 
glutamine is not charged and shorter than the arginine side chain, this residue 
may be the critical determinant of binding as suggested (Gustafsson et al., 2006). 
It would not be favorable for Arg280 to leave the “off position” in Ad7 and Ad14 
as no productive interaction with Gln279 would be possible.  
In order to test this hypothesis, a “rescue” mutant of Ad7 was constructed 
that carries an arginine at position 279. Interestingly, the affinity of the Ad7 knob 
for CD46 was drastically increased, to about 50% of that observed for the Ad11-
CD46 interaction. This indicates that the Arg279 residue indeed serves as the 
major determinant of binding. Other, surrounding amino acids also contribute to 
stability of complex formation, but they are not major determinants of affinity. 
The key amino acid for a stable complex is therefore the arginine at position 279.  
Taken together our data indicate that Ad7 and Ad14 interact with CD46 
but probably in a different way than is seen with Ad11. Thus, the presence or 
absence of a single amino acid appears to determine whether CD46 can be 
bound with high affinity. 
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5.5 Mutations at the Ad11 knob:CD46 
interface 
In order to define the contributions of Ad11 knob residues for binding CD46, we 
performed a mutational study. Key amino acids of the Ad11 knob that were 
identified as interacting partners for CD46 were mutated to either serine or 
glycine, and in some cases to the corresponding amino acid in the Ad7 knob. 
Interestingly, with the exception of mutations of Arg279, very few mutations had 
significant effects on the overall affinity for CD46. The results from the mutational 
studies therefore strengthen our finding that Arg279 is the key determinant of 
binding to CD46. 
5.5.1 Mutation of Ad11-R279S and Ad11-R279Q  
As expected, the mutation of Ad11-R279 to Gln or Ser had a large effect on the 
affinity for CD46. The affinity of the Ad11 knob was reduced from 12 nM to 500 
nM in both cases (measured using SPR), indicating that the presence of an 
arginine at position 279 is key to a very high affinity interaction. On the other 
hand, these data also show that additional residues are important for binding 
because an affinity of 500 nM can still be considered high. Several of these 
additional residues were mutated in subsequent experiments (see below). The 
affinity of the Ad11-R279S mutant for CD46 is still about 100 fold higher than those 
of the Ad7 and Ad14 knobs, which also lack the arginine at position 279. Finally, 
these results show that the same affinity is seen with a serine and a glutamine at 
position 279. This confirms that the type of amino acid (large or small) does not 
matter much and that the switch of Arg280 from the “off” to the “on” position is 
not simply prevented by steric blockage with the larger glutamine side chain. 
The serine side chain at position 279 is too small to block the switch, and Arg280 
could easily fit next to it.    
5.5.2 Mutation of Ad11-I282L  
The isoleucine at position 282 faces towards CD46 residues Lys29 and Tyr36, 
making contacts with the hydrophobic portions of both. Mutation of Ile282 to a 
Leu reduced the affinity of Ad11 knobs for CD46, measured using ITC, five fold. 
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The most likely explanation is that, while Ile and Leu are both hydrophobic and 
have a similar molecular weight, the shape of the side chain matters in order to 
allow for a tight packing of both partners in the complex. Thus, the different 
overall shape of the leucine side chain likely affects the surface 
complementarity, thus lowering the affinity for CD46. 
5.5.3 Mutation of Ad11-R280G  
In the complex between Ad11 knob and CD46, the hydrophobic portion of the 
Arg280 side chain packs against the Phe35 sidechain of CD46. The guanidinium 
group of Arg280 forms a salt bridge with Glu63 of CD46. Moreover, the 
guanidium group also stacks next to the side chain of Arg279, forming an Arg-Arg 
sandwich as described above. The mutation of Ad11-R280 to glycine completely 
abolished binding to CD46, confirming the absolutely critical importance of this 
arginine for the interaction with CD46. In addition, the introduction of a glycine 
residue, could also have increased the flexibility of the HI-loop, which may have 
contributed to the complete loss of binding. 
5.5.4 Mutation of Ad11-N283S 
The Asn283 side chain forms a hydrogen bond with the backbone carbonyl 
atom of CD46-Y28. Mutating this residue to serine did not appreciably alter the 
affinity for CD46, which was measured using ITC. The mutation did probably not 
affect the affinity due to its position between the two solid interactions Ad11-
D284 to CD46-H43 and Ad11-R280 to CD46-E63. The mutation would create a 
cavity in which a water molecule could bridge the contact, thus not changing 
the affinity. Affecting the affinity by a mutation at this position would require a 
large bulky amino acid that would produce clashes between the two proteins. 
5.5.5 Mutation of Ad11-D284S 
In the complex, Asp284 forms a hydrogen bond to CD46-H43 and seals off the 
binding interface at one end. The Ad7 knob has an Asn this position, which 
would be able to make a similar contact, although the salt bridge would be 
replaced with a hydrogen bond.. The Ad14 knob has an Ala in this position, 
which would not be able to contact the His. As Ad14 and Ad7 knobs bind CD46 
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with similar (low) affinity, position 284 does not seem to be a “hotspot” that 
defines the high-affinity interaction with CD46. However, the Ad11 knob D284 
interaction with CD46-H43 was thought to at least contribute somewhat to the 
affinity. Surprisingly, the mutation did not affect the affinity in a measurable way 
(measured with ITC). A possible explanation is that a Ser at position 284 could 
also interact with the CD46-H43, perhaps via a bridging water molecule. The 
CD46-H43 side chain is fairly exposed, and modelling suggests that it could 
adopt an orientation that could engage the serine. 
5.5.6 Mutation of Ad11-N245S  
In the Ad11 knob-CD46 complex, Asn245 is engaged in a hydrogen bond with 
the guanidinium group of Arg280. This residue is located on the side opposite of 
that occupied by Glu63 of CD46, and it does appears to help fix the Arg280 side 
chain in place. However, this amino acid is conserved in Ad11 and Ad7, and thus 
probably not a major determinant for a high affinity interaction to CD46. As 
expected, mutating it did not alter the affinity of the Ad11 knob for CD46, 
indicating that this residue is not a determinant of binding to CD46.  
5.5.7 Mutation of Ad7-Q279R  
Mutation of the Ad7-Q279 to an arginine has been suggested to partially restore 
the binding capacity to CD46 (Gustafsson et al., 2006). If the presence of an 
arginine at position 279 is required to allow the Arg280 to switch from the “off”to 
the “on” position, then a mutation of Ad7-Q279R should result in relatively tight 
binding of the Ad7 knob to CD46. This was confirmed by our studies, wich show 
that the mutant Ad7 knob has nM affinity for CD46. 
5.5.8 Summary of the mutational analyses 
The interaction between Ad11 and CD46 covers an extensive interface, 
occluding a total of 1600 Å2 from solvent. Many interactions are main chain 
interactions. These interactions can therefore not be probed through 
mutagenesis experiments. However, several side chains form contact points 
between the two proteins. Mutating these residues one at a time will in most 
cases result in only a small (or no) change. This is in keeping with the observation 
Discussion 
 111 
that many contacts, together, provide the high affinity seen for the complex. 
Change of any one amino acid will perhaps reduce the affinity somewhat, but 
the many remaining contacts will be able to absorb this loss and still be able to 
bind CD46 tightly. The major exceptions are of course the Arg280 and Arg279 
residues, both of which need to be present for a productive interaction with 
nanomolar affinity. Without Arg280 no interaction is possible at all, indicating that 
charge-charge interactions between Arg280 and CD46-residue Glu63 are a 
critical component of complex formation. Thus, the following scenario emerges 
from our studies. Charge-charge interactions cover a longer distance than 
hydrophobic interactions or hydrogen bonds. It is therefore conceivable that the 
Arg280 interaction with CD46 serves as the initial attraction force once the 
molecules are in closer vicinity– if it is not present the initial contact will not be 
made at all. Once the Arg280 has been engaged, the remaining contacts are 
made, providing additional energy through the fine-tuning of interactions of a 
hydrophobic (e.g., Ile282) or polar (e.g., Asn245, Asp283) nature. Because there 
are many of these secondary interactions, mutation of any one of them does not 
yield dramatic effects.  The role of Arg279 is critical in that it stabilizes and orients 
Arg280 in a position (the “on”-position) so it can make this initial contact. In the 
Ad7, Ad11 and Ad14 knobs, the Arg280 side chain is in the off position prior to 
binding CD46. Very high affinity interaction with CD46 is possible only for Ad11 
knobs, which do have an arginine at position 279. Without it, as in the Ad11-R279S 
mutant, the Arg280 probably does not want to leave its “off” position.  
5.6 Comparison of ITC and SPR 
In this work, we have presented affinity data obtained with both ITC and SPR. 
Initially, ITC was used to determine affinities as SPR equipment was not available. 
As measuring interactions using SPR became possible due to the purchase of a 
BiaCore 2000 system, we changed methods. Initially, this was done primarily in 
order to reduce the amount of required protein. However, as some proteins were 
remeasured using SPR the measured affinity did not agree fully with the ITC data. 
With high affinity data in the lower nM range a 10 fold higher affinity value was 
obtained using ITC, which can be considered as the same order of magnitude. 
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However, for lower µM affinities of the Ad7 and Ad14 knobs we did not observe 
any binding using ITC. 
 ITC relies on measuring heat that is generated or lost during an interaction 
(see Methods section 3.5). By contrast, SPR detects a change in mass close to 
the chip surface (see Methods section 3.5). In our experimental setup for ITC, we 
assumed a high affinity for the Ad11 knob interaction with CD46, and the same 
setup was later used for all the mutants as well as for Ad7 and Ad14 knobs. It is 
very likely that this setup does not allows a detection of the lower affinity, and 
that if the setup would be optimized some affinity could be measured. We did 
not alter the setup to detect this affinity since the consumption of protein would 
be too large. Measuring Ad11 knob affinities required about 2 ml of a 2 µM Ad11 
knob solution and 350 µl of a 25 µM CD46 solution. In order to measure the much 
weaker-binding Ad7 and Ad14 knobs, we would have needed a >1000 fold 
higher concentration of CD46, which is not possible. Additionally, the mutations 
were designed to abolish favorable interactions in the complex, thus reducing 
the energy released to the system. This would have required even higher 
concentrations of proteins. For these reasons, we switched to SPR.  
 SPR offered several advantages: (i) we could use smaller volumes of 
protein with (ii) lower concentrations and did not have to (iii) rely on energy 
released but on detecting a change in mass. Binding could also be (iv) observed 
in real time, and the measurement could be interrupted in order to save protein 
if no binding was detected. We connected the Ad knobs to the chip to avoid 
measuring avidity, which occurs when several proteins on the chip interact with 
one protein molecule in the solution. Avidity makes the binding model fit less well, 
with a risk of biasing the data. We also used CM5 chips for covalently attaching 
the knobs, which made the setup more expensive but reduced nonspecific 
binding of CD46 in the flow cells. However, each experiment was always 
performed in duplicates. The affinity data recorded using SPR can also be cross-
validated by using several experimental setups. We collected, in duplicates, 
affinity data using two different setups, solution affinity and steady state affinity. 
Our data correlate well and can be considered as reliable. 
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5.7 Conclusions 
The structure of the Ad11 knob in complex with CD46 defined, for the first time, 
how CD46 is recognized by a pathogen. Many pathogens use CD46 for 
attachment, but the mode of interaction has so far remained elusive. Moreover, 
other receptors with a similar domain structure (CD21, CD55) also serve as viral 
receptors, but again no information is available on the modes of recognition.  ln 
addition, the structure shown here represents the very first example of a virus 
protein distorting the overall conformation of its receptor, and thereby the 
pattern of amino acids on the receptor surface. Known atomic-resolution 
structures of complexes between viral proteins and protein receptors include 
complexes between HIV gp120 and its receptor CD4 (Kwong et al., 1998), 
between a CAR-binding Ads (Ad12) and CAR (Bewley et al., 1999), between 
Epstein Barr Virus (EBV) glycoprotein 42 (gp42) and the MHC class II molecule 
HLA-DR1 (Mullen et al., 2002), and between Herpes Simplex Virus and HveA (Carfi 
et al., 2001). In addition there is a lower-resolution structure of human rhinovirus 
complexed with its receptor ICAM-1 (Bella et al., 1998).  The structures of the 
complexes all share a common feature, with an interaction between the two 
components without any major conformational changes in the receptors. The 
cellular receptors are bound essentially as rigid bodies, and structural changes 
are limited to alteration of the orientation of very few side chains. In the structure 
presented here, we see a profound alteration of the receptor structure and its 
surface. Binding of the Ad11 knob to CD46 alters the relative orientation of the 
outer two domains, which adopt an elongated rod-like shape. It is intriguing to 
speculate that, perhaps, the changes in CD46 structure are linked to altered 
signalling behavior of this receptor. Recent data indicate that CD46 plays a role 
in signalling, and that its signalling properties can be modulated by ligation. 
Antibody cross-linking of CD46 has shown to alter polarization of T-cells, thus 
connecting ligand binding to cell signalling (Oliaro et al., 2006). In the crystal 
structure of CD46 SCR1-SCR2, the crystallized protein formed trimers that are 
believed to also occur at the cell surface (Casasnovas et al., 1999). These trimers 
were formed through interactions between SCR1 domains. It is tempting to 
speculate that Ad11 binding would disrupt trimerization, as the Ad11 knob 
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engages a surface of SCR1 that is also used for trimerization. In addition to 
determining the structural basis of Ad attachment to CD46, we also performed 
an analysis of the roles of each of the contact residues. This allowed us to 
postulate a binding mechanism that is primarily driven by two arginines that act 
in concert to engage the CD46 receptor. An unusual Arg-Arg stack is at the 
center of this interaction, and it remains to be seen if other viruses or pathogens 
use similar mechanisms to engage CD46 or related receptors. The measles virus 
hemagglutinin, for example, is also known to bind to a large surface on domains 
SCR1 and SCR2 (Casasnovas et al., 1999), and it is therefore likely to also engage 
in contacts with residues that interact with the Ad11 knob. 
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6 Outlook 
Although several important results have been obtained in this thesis, many 
questions remain. It is for example not entirely clear how other B-type Ad knobs 
engage CD46. This is especially true for Ad35, whose knob is quite different in 
loop structure to that of Ad11, and its close homolog Ad21. We will initially try to 
solve the structure of a second complex, performing in parallel crystallization 
tirals with both the Ad35 knob as well as the Ad21 knob in complex with CD46. 
Additional efforts will focus on crystallizing Ad knobs in complex with a longer 
fragment of CD46 comprising SCR1-SCR4. The main motivation here is to obtain a 
structure of full-length CD46, which has so far remained unsuccessful. Isolated 
CD46 SCR1-SCR4 crystallizes but the crystals diffract poorly, indicating that 
flexibility is present in the CD46 molecule. In complex with Ad11, this protein will 
likely be less flexible and perhaps more amenable to crystallization. This structure 
will reveal the overall architecture of SCR3-SCR4, including properties of binding 
sites for other proteins that are located on these domains. 
 We have also started to investigate how other pathogens bind CD46, and 
to study the role of pathogen binding in cell signalling. Using SPR, we will map the 
binding sites for several pathogens in order to create a “pathogen map” of 
CD46. If several pathogens share a similar epitope, this epitope could be an 
important target for drug design. We will also repeat all ITC measurements using 
SPR, stepwise converting the HI-loop of Ad7 to Ad11 and thus mapping the 
contribution of each amino acid. The goal is to reach the Ad11 affinity for CD46 
with a modified Ad7 knob. These experiments will help us complete the picture of 
the Adenovirus: CD46 interaction.  
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7 Appendix 
7.1 Ad fiber sequences 
Table I. Gene sequences for the expressed Ad knobs 
 
Ad type Amino 
Acid 
number 
Mutation Construct Name Genebank number 
Ad7 118-325  Ad7 AY594255 
Ad7 118-325 Q279R Ad7-Q279R AY594255 
Ad11 118-325  Ad11 AAN62521 
Ad11 118-325 N245S Ad11-N245S AAN62521 
Ad11 118-325 R279Q Ad11-R279Q AAN62521 
Ad11 118-325 R279S Ad11-R279S AAN62521 
Ad11 118-325 R280G Ad11-R282G AAN62521 
Ad11 118-325 I282L Ad11-I282L AAN62521 
Ad11 118-325 N283S Ad11-N283S AAN62521 
Ad11 118-325 D284S Ad11-D284S AAN62521 
Ad14 123-325  Ad14 AAW33140 
Ad21 118-325  Ad21 AAA16493 
Ad35 118-325  Ad35 AY271307 
Ad35 123-325  Ad35short AY271307 
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7.2 ITC data 
 
 
Figure A. ITC data for knob binding to CD46 SCR1-SCR2 (A) Ad7 (B) Ad7-Q279R 
 
 
 
Figure B. ITC data for knob binding to CD46 SCR1-SCR2 (C) Ad11 (D) Ad11-I282L 
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Figure C. ITC data for knob binding to CD46 SCR1-SCR2 (E) Ad11-N283S (F) Ad11-D284S 
 
 
 
Figure D. ITC data for knob binding to CD46 SCR1-SCR2 (G) Ad11-R279Q (H) Ad11-R279S 
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Figure D. ITC data for knob binding to CD46 SCR1-SCR2 (I) Ad11-R280G (J) Ad21 
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7.3 Crystallographic data statistics 
Table II. X-ray crystallographic data for the Ad11, Ad7 and Ad14 knob 
 
 Ad11 knob Ad7 knob Ad14 knob 
Data collection    
Space group I23 P21212 P3212 
Cell dimensions    
    a, b, c (Å) 100.6,  
100.6,  
100.6 
83.31, 
88.05,  
79.17 
106.47, 
106.47,  
311.71 
    α, β, γ  (°)  90.00,  
90.00,  
90.00 
90.00,  
90.00,  
90.00 
90.00,  
90.00,  
120.00 
Resolution (Å) 40-1.45 (1.45-
1.50) * 
79-1.75 (1.75-
1.81) * 
47.4-1.8 (1.80-
1.90)* 
Rsym 4.5 (38.8)* 5.0 (36.4)* 7.8 (27.0)* 
I / σ 13.2 (1.6)* 10.17 (1.3)* 20.9 (5.2)* 
Completeness (%) 99.9 (100.0)* 99.1 (95.1)* 99.1 (94.4)* 
Redundancy 6.0 (5.4)* 5.1 (4.6)* 11.9 (4.8) 
    
Refinement    
Resolution (Å) 40.0-1.45 79.06-1.75 40.0-1.8 
No. reflections 30051 58882 185418 
Rwork / Rfree 18.8/21.6 20.2/23.8 19.2/21.2 
No. atoms 1754 5095 15979 
    Protein 1574 4626 13975 
    Ligand/ion/glycans    
    Water 180 469 2004 
B-factors (Å2)    
    Protein 13.7 21.8 19.0 
    Ligand/ion    
    Water 24.9 36.6 24.4 
R.m.s. deviations    
    Bond lengths (Å) 0.005 0.008 0.006 
    Bond angles (°) 1.15 0.945 1.071 
*Highest-resolution shell is shown in parentheses. 
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Table III. X-ray crystallographic data for the Ad11: CD46 SCR1-SCR2 complex 
 
 Ad11:CD46 SCR1-SCR2 
Data collection  
Space group P3 
Cell dimensions  
    a, b, c (Å) 106.14,  
106.14,  
68.34 
    α, β, γ  (°)  90.00,  
90.00,  
120.00 
Resolution (Å) 40-2.85 (2.85-2.95) * 
Rsym 13.8 (32.5)* 
I / σ 7.23 (2.64)* 
Completeness (%) 93.1 (83.0)* 
Redundancy 4.1 (4.0)* 
  
Refinement  
Resolution (Å) 40-2.85 
No. reflections 18934 
Rwork / Rfree 23.8/27.3 
No. atoms 5249 
    Protein 5134 
    
Ligand/ion/glycans 
81 
    Water 34 
B-factors (Å2)  
    Protein 45.8 
    Ligand/ion 58.2 
    Water 32.4 
R.m.s. deviations  
    Bond lengths (Å) 0.008 
    Bond angles (°) 1.5 
*Highest-resolution shell is shown in parentheses. 
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Table IV. X-ray crystallographic data for crystallized mutant knobs 
 
 Ad11-N245S Ad11-R279S Ad11-I282l Ad11-N283S Ad7-Q279R 
Data collection      
Space group I23 P32 I23 I23 P21212 
Cell dimensions      
    a, b, c (Å) 101.66, 
101.66, 
101.66 
148.65, 
148.65,  
74.44 
102.63, 
102.63, 
102.63 
101.41, 
101.41, 
101.41 
83.13,  
87.8,  
79.1 
    α, β, γ  (°)  90.00, 90.00, 
90.00 
90.00, 90.00, 
120.00 
90.00, 90.00, 
90.00 
90.00, 90.00, 
90.00 
90.00, 90.00, 
90.00 
Resolution (Å) 71.8-1.6 (1.6-
1.66) * 
129.1-2.55 
(2.55-2.64) * 
72.5-1.8 
(1.80-1.86)* 
71.8-1.72 
(1.72-1.78)* 
79.05-1.55 
(1.55-1.61)* 
Rsym 7.4 (44.0)* 9.7 (38.9)* 6.4 (38.2)* 8.5 (38.2)* 6.3 (38.9)* 
I / σ 14.2 (1.8)* 7.42 (1.2)* 7.2 (5.7)* 16.65 (1.22)* 12.8 (1.4)* 
Completeness 
(%) 
99.9 (100)* 99.0 (98.1)* 98.2 (86.2)* 99.7 (99.4)* 98.2 (95.8)* 
Redundancy 7.3 (7.1)* 3.2 (2.9)* 16.8 (1.66) 6.2 (2.7) 5.4 (5.3) 
      
Refinement      
Resolution (Å) 71.8-1.66 129.1-2.55 72.5.0-1.8 71.8-1.72 79.06-1.55 
No. reflections 21984 53384 14847 17590 74740 
Rwork / Rfree 19.4/22.0 21.3/23.6 20.2/23.8 17.8/22.0 19.2/21.2 
No. atoms 1670 14346 1668 1705 4922 
    Protein 1554 14033 1556 1554 4620 
Ligand/ion/ 
glycans 
     
    Water 116 313 112 151 302 
B-factors (Å2) 19.9 44.7 32.5 28.9 23.8 
    Protein 16.6 45.5 28.6 22.8 20.8 
    Ligand/ion      
    Water 23.3 41.0 36.4 35.0 26.8 
R.m.s. deviations      
Bond lengths (Å) 0.007 0.007 0.007 0.011 0.005 
Bond angles (°) 1.4 0.783 0.713 0.908 0.897 
*Highest-resolution shell is shown in parentheses. 
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